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Abstract 
Background: Tuberculosis (TB) is one of the most important infectious diseases globally. 
Case detection and treatment is the main method of prevention and control of TB. 
Defaulting from Directly Observed Treatment Short Course (DOTS) is a big challenge to the 
effective control of TB. The upsurge of TB in Nigeria and the poor management control has 
led to poor treatment outcomes of which defaulting is a major problem. Thus we embarked 
on this study in Benin City to determine the defaulter rate and factors that are associated 
with defaulting. 
Methodology: A retrospective case control study of TB patients placed on DOTS was 
conducted on 262 patients (99 defaulters and 163 non-defaulters) from August to 
December 2011. Cases were patients who did not complete treatment (defaulters) and 
control were patients who completed treatment (non-defaulters). Hospital records of 
patients placed on treatment from August 2006 to December 2010 were reviewed. From 
the 1,253 patients placed on treatment between this period, using the inclusion and 
exclusion criteria in screening patients, we had complete information from 722 patients 
comprising of 172 defaulters and 550 non-defaulters. From this number, 262 patients were 
recruited for the study. Data were analyzed using SPSS statistical software. Univariate and 
multivariate logistic regression analysis to determine association with defaulting was 
performed.    
Result:  The defaulting rate in this study was 172 (23.8%). Factors significantly associated 
with defaulting in the multivariate analysis were male sex (AOR 3.05; 95%CI 1.60-5.80), 
being a civil servant/professional (AOR 0.24; 95%CI 0.08-0.70), being married (AOR 3.06; 
95%CI 1.34-6.99), travelled out of locality during treatment (AOR 6.87; 95%CI 3.19-14.80), 
concomitant drug use with TB drugs (AOR 1.95; 95%CI 1.02-3.73) and occasional counseling 
about TB by service provider (AOR 0.05; 95%CI 0.01-0.28). In the univariate analysis, no 
privacy given by health workers showed a significant association with defaulting (OR 2.39; 
95%CI 1.39-4.09).   
Conclusion: The high default rate and the factors significantly associated with defaulting 
in this study has given us some information initially unavailable about defaulting from DOTS 
in Benin City and also the challenges faced by patients in the in the course of TB treatment. 
TB control strategy accorded to these areas is highly recommended. 
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 1     CHAPTER I:  INTRODUCTION 
 
1.1   Nigeria:   Country profile 
1.1.1 History 
Nigeria a country with rich diversity of people and culture came into existence as a nation in 
1914 through the amalgamation of the Northern and Southern protectorates by the British 
colonialism. Prior to the amalgamation, various different cultural, ethnic and linguistic 
groups existed such as Oyo, Benin, Nupe, Jukun, Kanem-Borno, Hausa-Fulani, Igbo, Ibibio and 
Tiv. These ethnic groups accounted for nearly 80% of the total population. 
There are about 374 identifiable ethnic groups with the Yorubas, Hausas and Ibos in the 
majority. Most of its population is concentrated in the southern part of the country, as well 
as in the area of dense settlement around Kano in the north. Between the two areas is a 
sparsely populated middle region.Nigeria became fully independent in 1st October 1960 as a 
federation of three regions (Northern, Western, and Eastern) under a constitution that 
provided for a parliamentary system of governance. The Lagos area became the Federal 
Capital Territory (1). 
 
1.1.2  Geography and climate 
Nigeria lies between 4
0
16’ and 13
0 
53’ north latitude and between 2
0
40’ and 14
0 
41’ east 
longitude and has an area of 924,400 square kilometres, one of the largest in Africa. Its 
geography varies greatly from tropical rainforest in the south to dry savannah in the north, 
which is flat and sparsely vegetated. The south eastern part of the country is hilly and 
mountainous along the border with Cameroon and also the central part, where Jos Plateau 
rises to 5,000 feet above sea level. Nigeria has borders with four countries: the Republic of 
Benin in the west, Republic of Niger in the north, Republic of Chad in the north-east and 
Cameroon in the east. It shares boundary also with the Atlantic Ocean in the south. Notable 
geographical features in Nigeria are the Adamawa highlands and the Mambilla Plateau in the 
north, Jos Plateau in north central, Obudu Plateau and Niger Delta in the south-south. 
 
Nigeria has a tropical climate with distinct wet and dry seasons associated with the 
movement of two dominant winds: the rain-bearing south west winds and the cold, dry, and 
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dusty north east winds commonly referred to as the Harmattan. The dry season occurs from 
October to March with a spell of cool, dry, and dusty Harmattan wind felt mostly in the north 
in December and January. The wet season occurs from April to September. The temperature 
in Nigeria oscillates between 25° and 40°C. The southern part of Nigeria experiences heavy 
and abundant rainfall with an annual rainfall of above 2,000mmwhile in the northern part it is 
500mm (2).  
 
1.1.3   Administrative setup 
Nigeria a federation of 36 states with Abuja (Federal Capital Territory) is grouped into six 
geopolitical regions: North Central, North East, North West, South East, South West and 
South-South. There are also 774 constitutionally recognized Local Government Areas (LGAs). 
For administrative purposes, the country is divided into 3 tiers of government namely federal, 
state and local government. At the federal and state levels, there is the executive, the 
legislative and the judiciary. The executive powers of the federation are vested in the 
president who is the Chief Executive of the Federation and Commander-in-Chief of the 
Armed Forces. The legislative arm at the federal level comprises of the Senate (upper 
chamber) and House of Representatives (lower chamber). The Senate has 109 members 
representing 109 senatorial districts across the country, while the House of Representative 
has 360 members from 360 federal constituencies in the country. Members of both arms are 
elected for a term of four years. A joint session of both arms is called the National Assembly 
(3). 
 
1.1.4  Economy 
Nigeria has rich and abundant natural resources in agriculture and minerals. Before the 
discovery of oil, the country depended almost entirely on agriculture for food and agro 
industrial raw materials for foreign exchange earnings. Agriculture provided gainful 
employment to over 75% of the country’s labour force and 90% of the population at the time 
of the country’s independence. With the discovery of oil, there was a turn of events, oil 
became the main source of revenue and has accounted for more than two thirds of the 
country’s Gross Domestic Product (GDP) and more than 80% of total government revenue. 
Nigeria is the 12th largest producer of petroleum in the world, the 8th largest exporter and 
has the 10th largest oil reserve in the world (4). Despite its huge resources, it is one of the 
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poorest countries in the world, with Human Development Index (HDI) of 0.459 ranking 156 
out of 187 countries (5). About 66% of Nigerians live on less than one U.S. dollar per day. It is 
also a member of the Organization of Petroleum Exporting Countries (OPEC). Its GDP grew by  
7.7% in the fourth quarter of 2011.  From 2005 to 2010, the average quarterly GDP Growth 
was 6.71% reaching an historical high of 8.29% in December of 2010 and a record low of 
4.50% in March of 2009 (6). 
 
1.1.5 Demography 
Nigeria is the most populous country in Africa with a population of 140,003,542 (2006 
census), with 71,709,859 males and 68,293,683 females. A higher number of the population 
live in rural areas (51.7%) while 48.3% live in urban areas.  45% of the population is under 15 
years of age (4).The older population of 65 years and above constitute only 3.3% of the                                  
population. The overall dependency ratio for the country is 93.2 dependents per 100 
workers.  
The dependency ratio has remained relatively stable at about 94%.                                                                                                                                  
Nigeria has an annual population growth rate of 2.83% with male/ female ratio remaining the 
same from 2003-2006 (see table 1 below). 
 
Table 1 Population distribution by sex and average growth rate in Nigeria 
Year Total Male Female 
 
Male/Female(%) 
 
Growth rate(%) 
  
2003 128,450,450 67,436,486 61,013,964 105 2.83 
2004 132,191,469 69,400,521 62,790,964 105 2.83 
2005 136,041,442 71,421,757 64,619,685 105 2.83 
2006 140,003,542 71,709,859 68,293,083 105 2.83 
  Source: National Population Commission Abuja, Nigeria 2006 
 
The Total Fertility Rate (TFR) for the country is 4.73 children per woman. The birth rate is 
35.51 births/1,000population from 2011 estimates. The rapid rate of rural-urban migration is 
partly responsible for the high rate of urbanization in the country with its consequent urban 
problems of housing, sanitation, waste management and crime. 
 
 
12 
 
1.1.6  Education 
In Nigeria, the literacy status of the population is low; the total adult literacy rate is 65.70% 
[74.60% for male, and 56.80% for females] (2). There are acute shortages of infrastructure 
and facilities at all levels. Access to basic education is inhibited by gender issues, socio 
cultural beliefs and practices in some parts of the country. According to the Nigerian MDGs 
Report 2010, literacy level in the country has been fluctuating within the 15-24years group. 
The literacy rate was 64.1% in 2000 declined to 60.4% in 2003 before rising to 80% in 2008. 
The net enrolment ratio in primary education was 68% in 2000, with a steady but slow 
increase, the gross enrolment rose to 88.8% in 2008 (7). There is a also  a great imbalance in 
the enrolment, attendance and completion rates in all levels of education among girls in 
Nigeria particularly in the northern parts of Nigeria due to a variety  of socio-cultural and 
religious factors. It is estimated that 7.3 million school age children are out of primary school 
majority of them girls (8). 
 
1.2  Health profile of Nigeria 
1.2.1 Health service status 
The national health care system is built on the basis of the three-tier responsibilities of the 
federal, state and local governments. Nigerian health system includes the orthodox, 
alternative and traditional systems of health care delivery. The government recognises and 
regulate these three systems. There are three levels of health care delivery: primary, 
secondary and tertiary managed by the local, state and federal governments respectively.  
 
The formal health care sector is operated with Primary Health Care (PHC) as the cornerstone 
of the National health policy. A health sector reform was introduced in 2004 to address the 
apparent lack of accountability in the Primary health care services. The primary health care 
services provide health education; adequate nutrition; safe water and sanitation; 
reproductive health including family planning; immunization against major infectious 
diseases: provision of essential drugs: disease control; mental health and dental health at the 
local government level. The secondary health care provides specialized services to patients 
referred from the primary health care level and it is the responsibility of the state 
government. The tertiary health care provides highly specialized, referral services to patients 
referred from primary and secondary levels of health care delivery systems (2). 
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In order to improve the access of health care services, the National Health Insurance scheme 
(NHIS) was established in 2005. About 5 million Nigerians have been enrolled in the scheme. 
However, it is intended that by 2013 40% of the population would have been covered. 
Similarly, the National Health Bill was passed in 2008 to ensure equitable access to health 
services by all Nigerians especially the vulnerable groups including women and children. It 
ensures that children have increased access to basic health care services. An Integrated 
Management of Childhood Illness Strategy through the Primary Health Care centres was 
expanded to cover families and communities both in rural and urban areas. Coverage has 
been expanded from six states in 1999 to thirty three states in 2007 including the Federal 
Capital Territory (2). 
 
The health system performance is ranked 187th among the 191 member States, the 2006 
MDG report of the country indicates that the country is still struggling to meet the MDG 
health goals (9). 
 
1.2.2   Health status of the population 
The health status indicators for Nigeria are among the worst in the world. On average, the 
health status of the population has declined compared with indicators a decade earlier.                                                                                                
Some of these health indicators also perform poorly compared to other countries with similar 
income per capital. Inequalities in health outcomes also exist between rural and urban 
groups, the northern and southern regions and across income groups. These poor outcomes 
are not only due to the high increase in the poverty level but also to the weaknesses in the 
health sector especially in the delivery of primary health care services (10).  
 
About 72% of deaths in Nigeria are due to communicable diseases (11). Infant mortality rate 
in 2008 was 75 deaths per 1,000 live births while the overall under-five mortality rate for the 
same period is 157 deaths per 1,000 live births (1). Maternal mortality rate is estimated at 
800 per 100,000 life births. Life expectancy at birth is 47 years, this is below the least 
developed countries average age of 53years with disability adjusted life expectancy at birth 
of 38.3years. The major contributors to the disease burden in Nigeria are diarrhoea, malaria, 
tuberculosis and HIV/AIDS. Malaria is major health and developmental problem with a 
prevalence of 919 per 100,000 populations. It is the major cause of morbidity and mortality in 
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infants and young children in the country, about 75% of deaths due to malaria occur in 
children under five and one in ten maternal deaths is due to malaria (4) (see table 2). 
 
Table 2 Main causes of morbidity and mortality in Nigeria 
        Main causes of morbidity 
 
   Value    (%)      Main causes of mortality  Value (%) 
      Malaria     70.5          Malaria    53.9 
      Diarrhoea     4.2          Diarrhoea    17.1 
      Dysentery     5.50          Pneumonia    7.40 
      Pneumonia     4.76          Dysentery    4.90 
      Sexually transmitted diseases     1.96          AIDS    3.30 
      Tuberculosis     0.36          CSM    3.25 
      Measles     0.37          Cholera    3.20 
      AIDS     0.37          Measles    1.80 
      Cholera     0.36          Neo-Natal Tetanus    1.40 
      Pertussis       0.30          Tuberculosis    1.30 
Source: Department of Public Health, Epidemiological Division, Federal Ministry of Health, 2006 
CSM: Cerebrospinal meningitis 
 
Tuberculosis and HIV/AIDS have seen a dramatic increase in Nigeria. This is attributed to the 
high poverty level. Adult prevalence of HIV/AIDS is 3.6% and about 2.9 million people are 
living with HIV/AIDS (4,12). The increase in HIV/AIDS has tremendously increased the 
prevalence of TB.  
 
1.3  Tuberculosis 
1.3.1   Introduction to tuberculosis 
1.3.1.1 Aetiology   
Tuberculosis is an infectious disease that is caused by a bacteria of the genus Mycobacterium. 
The species of Mycobacterium tuberculosis complex (MTC) consists of Mycobacterium 
tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium canettii and 
Mycobacterium microti. These species are the causative agents of TB in humans and animals. 
Mycobacterium tuberculosis (Mtb) is the major cause of TB in humans worldwide (13,14).It is 
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an acid-alcohol fast bacteria which can form acid-stable complexes when certain dyes are 
added. 
 
1.3.1.2   Mode of transmission of tuberculosis 
When a person with pulmonary TB coughs, sneezes, talks or coughs, the bacteria that causes 
TB spread throughout the air. Any person that breaths in the air is likely going to be infected 
with TB. Repeated contact is usually required for infection (15). However, not everyone 
infected with the TB bacteria will become sick. Roughly 5% of people infected with M.tb 
actually develop TB. People who are infected but not sick have latent TB infection. Those who 
have latent infection are asymptomatic and non-infectious. After 5 years without treatment, 
50% of TB patients often die, 25% will remain sick with chronic infectious TB and the 
remaining 25% will be spontaneously remitted by strong immune defences without 
treatment (16). The risk of being infected with TB is dependent on the concentration of 
droplets nuclei of  bacilli in  contaminated air, length of time a person breaths in air and the 
level of immunity. 
 
1.3.1.3  Clinical manifestation of tuberculosis 
Early symptoms of active PTB include weight loss, night sweats, persistent cough for two 
weeks or more, fever, fatigue and loss of appetite (15). Due to the vague initial symptoms of 
TB, an infected person may not feel that there is anything wrong. The infection can either go 
into remission or become more severe with the onset of chest pain and coughing of bloody 
sputum (17). 
 
 1.3.1.4    Diagnosis of tuberculosis 
Diagnosis of PTB is usually done using sputum specimen collected from suspected TB 
patients. Sputum sample collected is stained with aniline dye (carbol fuchsin) and then 
decolourised with acid alcohol and viewed under the microscope. Since M.tb has a waxy cell 
wall it will retain the dye i.e. cannot be decolourized by acid or alcohol thus can be easily 
detected by the microscope. It is this characteristic property they are named Acid Fast Bacilli 
(AFB). TB can also be diagnosed with chest X-ray if sputum smear result is negative. If TB is 
present, lesions on X-rays are often seen in the apical segments of the upper lobe or in the 
upper segment of the lower lobe of the lungs. However, lesions may appear anywhere in the 
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lungs especially in HIV-positive and other immunosuppressed persons (15). Culture test using 
Lowenstein Jensen medium can also be used in diagnosis of PTB. This test is used for a 
definitive diagnosis of TB in resource limited settings. However, its short coming is the long 
incubation period required in culturing TB bacilli with an average of 4 weeks needed to get a 
conclusive result (18).There are other diagnostic techniques such as interferon-gamma 
release assay, nucleic acid amplification test but because of their high cost and the 
requirement for sophisticated equipment and highly skilled personnel they have not been 
used on a routine basis in low income countries (19). 
 
1.3.1.5    Treatment of tuberculosis 
Mycobacterium tuberculosis is a very slow-growing, intracellular organism as such treatment 
requires the use of multiple drugs for several months. With appropriate antibiotic treatment, 
TB can be cured in most people. Treatment usually combines several different antibiotics that 
are given for at least six months, sometimes for as long as 12 months. The treatment regimen 
for TB include isoniazid, rifampicin, pyrazinamide and ethambutol. They are the first line 
drugs for TB treatment. They are called first line drugs because they are effective, side effects 
are tolerable and readily available. The second line drugs are the fluoroquinolones, 
aminoglycosides, polypeptides, thioamides, cycloserine and para-aminosalicylic acid. They 
are less effective, have toxic side effects and not readily available. They are mainly used for 
resistant TB cases. TB treatment has two phases; the initial phase has two months (new 
cases) or three months (re-treatment cases) and the continuation phase which is six months. 
In Nigeria, the regimen used is isoniazid, rifampicin, ethambutol, pyrazinamide and 
streptomycin (used for re-treatment cases). In the intensive phase, isoniazid, rifampicin, 
ethambutol and pyrazinamide are used while for the continuation phase isoniazid and 
rifampicin are used. The strategy of TB treatment is called Directly Observed Treatment Short 
Course (DOTS). It is a key component of the World Health Organization`s campaign to stop 
TB. It involves patient case management by trained health professionals who ensure that 
patients take their TB drugs (20). Patients take their medication in the presence of a 
designated health personnel for the first two months of treatment after which they are given 
monthly supply of drugs for six month to be self-administered at home. DOTS strategy has 
been successful in reducing the defaulting rates, with cure rates above 80% and default rates 
less than 10% (20). 
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1.3.2    Global tuberculosis burden 
Tuberculosis is a major public health problem globally. It has emerged as a leading cause of 
death from a single infectious agent globally. The prevalence, patterns of presentation and 
the mortality of TB vary from one country to another and from one region of a country to 
another. These variations depend on prevailing social factors such as socio-economic status 
of the people, malnutrition, crowded living conditions, incidence of HIV/AIDS, level of 
development of health infrastructures, quality of available control programmes and the 
degree of drug resistance to antituberculosis drugs (21). It was estimated that 1.7 million 
people died from TB in 2009 and 9.4 million people developed active TB (22). Of the 22 high 
burden countries (HBC) of TB, India, China, Indonesia, Nigeria and South Africa rank 1st to 5th 
respectively in terms of incidence cases. Africa account for a 31% incidence cases while Asia 
(South-East Asia and Western Pacific regions) account for 55%. The Africa region in 2006 
accounted for the majority of co-infections of TB with HIV cases worldwide, approximately 
85% (23,24,25).Some Africa countries account for a strikingly large number of cases relative 
to their population. South Africa for example, has 0.7% of world population but 28% of the 
global number of HIV positive TB cases and 33% of HIV cases in Africa (26). 
 
Tuberculosis is basically a disease of men. In places where the transmission of M.tb has been 
stable or increasing for many years, the incident rate is highest among young adults and most 
cases are due to recent infection or re-infection. In western Europe and north America which 
now have low incident rates, TB cases tend to be seen in older patients who are natives, 
whereas patients who are immigrants from high-incident countries tend to be young adults. 
Reports from countries indicated that 1.4 million smear-positive cases where seen in men, 
but only 775,000 in women (27). This epidemiological difference is suggested to be due to 
gender difference in accessing TB services, exposure to infection and susceptibility to develop 
an active disease (27). 
 
However, the incidence rate of TB per head seems to be growing slowly in the world as a 
whole, case notification rates have been steady or falling for at least two decades in the 
South East Asia and Western Pacific regions, developed economies and central Europe, Latin 
America and Eastern Mediterranean regions. The global increase is attributable to the 
proliferation of cases in Eastern Europe (mainly the former Soviet Union) since 1990 and in 
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sub-Sahara Africa since the mid-1980s. However, trends in case reports suggest that the rate 
of increase in both regions has slowed considerably since the mid-1990s and the incidence in 
eastern Europe might now be in decline (28,29). From results of periodic surveys, more than 
10% of new TB cases in Estonia, Latvia and some parts of Russia are Multi drug resistant TB 
(MDR-TB) i.e. TB that is resistant to at least isoniazid and rifampicin the two most effective 
drugs for treatment of TB (30,31). It has been shown that some parts of eastern Europe are 
hotspots for MDR-TB, only 3% of all cases globally every year are estimated to be multi-
resistant (32). 
 
Much of the increase in global TB incidence seen since 1980 is attributable to the spread of 
HIV in Africa (28,29,33). Globally, an estimated 13% of adults with newly diagnosed TB were 
infected with HIV in 2004 with variations among regions, from 34% in Africa to 1.4% in the 
western pacific region. Rates of HIV infections in patients with TB have remained below 1% in 
Bangladesh, China, Indonesia and Pakistan. In Africa with high rates of HIV infections, a 
relatively high proportion of patients with TB are women aged 15-24 years (28,23). When HIV 
infection rates are high in the general population they tend to be high also in patients with TB 
with estimates in 2004 exceeding 50% in Botswana, South Africa, Zambia and Zimbabwe. 
 
In line with the global scourge of TB, WHO and International Union Against Tuberculosis and 
Lungs Disease (IUATLD) developed the DOTS strategy in 1995 for the treatment of TB 
globally. It is a short course chemotherapy (a minimum of six months) that combines 
appropriate treatment and management of TB patients starting with registration of each 
patient detected through proper diagnosis to administration of standardized multi-drug 
regimen with supervision from a trained health professional. It has five key components 
namely: 
 
1. Political commitment with increased and sustained financing. 
2.  Case detection through quality assured bacteriology. 
        3.  Standardized treatment with supervision and patient support. 
        4.  An effective drug supply and management system. 
        5.  Monitoring and evaluation system and impact measurement. 
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1.3.3   Tuberculosis in Nigeria 
1.3.3.1 Tuberculosis epidemiology in Nigeria 
Tuberculosis (TB) is endemic in Nigeria. Among the 22 HBC of TB in the world, Nigeria ranks 
4th and has the highest number of new TB cases in Africa. An estimated 300,000 TB cases are 
recorded every year resulting in more than 30,000 deaths annually (34). The detection of 
smear-positive cases tripled between 1996 and 2004, the overall case detection rate was 
27%,while the treatment success rate of new sputum smear positive patients was 76% (34). 
Both are still far below the WHO target for case detection rate of 70% and treatment success 
rate of 85% (26). 
 
The HIV epidemic in Nigeria has increased the incidence of TB and also made the TB case 
detection more challenging. The National AIDS and Sexually Transmitted Infection Control 
Programme (NASCAP) estimated a 6% increase in the number of TB cases as a result of the 
HIV/AIDS epidemic (35). Nationally, the HIV prevalence among TB cases increased more than 
4-fold between 1991 and 2001. From WHO estimate, 27% of adult TB patients in the country 
are HIV-positive (36). 
 
The high incidence of TB coupled with the HIV epidemic and the weak health care system 
have been a breeding ground for the proliferation of MDR-TB in Nigeria (37,38). Prevalence 
of MDR-TB is about 2.2% among new cases and 9.4% among re-treatment cases. Despite this 
high prevalence, facilities for the diagnosis of MDR-TB are not readily available and treatment 
largely unavailable. TB diagnosis in Nigeria is still largely rudimentary, relying mainly on 
sputum smear microscopy. In cases where MDR-TB is suspected, the inability to make 
bacteriological diagnosis stalls further patient management. Where facilities are available, 
they are often unaffordable (39).In line with WHO and Stop TB partnership’s call for 
significant capacity in TB case detection, the Nigerian government has made efforts to 
provide diagnostic facilities in six zonal laboratories in the country. However, WHO estimates 
of TB burden in Nigeria is shown in table 3 below (40). 
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Table 3   Showing WHO (2011) estimates of TB burden in Nigeria 
 
                                 No.                                            Rate 
                                        (Thousands)                         (per 100,000 pop)              
   TB Mortality( excl. HIV)            33 (11-68)                              21(7.2-43) 
   Prevalence (incl. HIV)               320(110-690)                       199(70-438) 
   Incidence (incl. HIV)                  210(99-360)                         133(63-228)   
   Case detection , all forms (%)    40(23-85)                                         
 Source: WHO global TB control report, 2011 
 
 
The figures above are based on 2010 population estimate of Nigeria which was 158 million. 
There has been an improvement in TB case detection rate in Nigeria over the years. A nine 
year review from 2000 to 2008, showed an increase in case detection rate (CDR)from 14.0% 
in 2000 to 31.0% in 2007 with a slight decline to 30.5% in 2008 (41) (See figure 1 below). 
 
Figure 1   A nine year review of TB case detection rate in Nigeria, 2008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: National TB and Leprosy Control Programme, FMOH 2008 
 
According to National TB Control Programme (NTBCP), a total of 90,311 of all forms of TB 
cases were registered in 2008. From this figure, 83,263 (95%) were new cases and 8% were 
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re-treatment cases. Sputum smear positive cases constituted 51% (46.026) of new cases. 
Over a seven year period (2002-2008), there was 189% increase in the total number of 
registered cases from 31,164 to 90,311 respectively. There was also differences in TB cases 
registered in each states with an average of 2,441 TB cases per state in 2008. Lagos state had 
the highest 9,864 cases. The distribution of TB cases within the six geopolitical regions of the 
country showed some variations. The South West had the highest 20,833 (23%) while the 
South East had the lowest 8,218 (9%) (41)  (Figure 2). 
 
Figure 2 Shows Zonal TB Notification rates in Nigeria, 2008 
 
Source: National TB and Leprosy Control programme, FMOH 2008 
 
The distribution by age and sex of smear positive TB cases in the country also show some 
variations. In 2008, TB case detection for females and males aged between zero and above 
sixty five years was 18,568 (40.3%) and 27,458 (59.6%) respectively. The case notification for 
new smear positive TB cases for children (both sexes) under 15 years of age was 1,324(3%) of 
new smear positive TB cases notified. 24,862 (54%) of smear positive cases notified in 2008 
were in the age bracket 15 -45 years of age. 
 
1.4   Defaulting from Directly Observed Treatment Short Course (DOTS) 
Tuberculosis treatment requires long duration of drug administration. By virtue of this, 
patients find it difficult to complete treatment most especially when they feel relieved after 
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taking medication for the first two months of treatment. Poor adherence to prescribed 
medications increases the risk of morbidity, mortality and spread of disease in the 
community. Poor adherence to anti-TB medication is a major barrier to global TB control 
(42,43,44).  
 
There are some factors that are associated with defaulting from DOTS. The health care 
system, patients related factors, socio-economic and cultural factors have influence on TB 
treatment defaulting. A study in Ethiopia showed that of the 1206 new TB patients registered 
on DOTS, 82% were found to have defaulted (45). Defaulting occurred mostly in the third and 
fourth month of treatment. Reasons for defaulting were inadequate knowledge about the 
disease, treatment duration, medication side effects, feeling of improvement and close 
distance to treatment centre. An Indian study showed that TB treatment defaulting was 
associated with alcohol and tobacco use (46). 
 
A case control study in New York on TB treatment default reveled that most patients default 
treatment due to lack of awareness of the severity of TB disease (47). In Hamburg, a 
prospective evaluation was carried out on 518 TB patients to determine the risk factors 
affecting treatment outcome and found 54 (10.4%) defaulted treatment; alcoholism, 
homelessness and drug addicts were found to have a higher risk of treatment interruption 
(48). There was also a link between defaulting and alcoholism in a study in Colorado (49) 
 
Tuberculosis is highly stigmatized in the African setting. They see TB as associated with 
poverty and uncleanness. TB patients face evictions by their house owners, divorce, 
avoidance, loss of job, less respected in the community and other humiliations. These have 
greatly influenced patients noncompliance to treatment. A study showed that societal 
stigma, discrimination and denial, poor access to health facilities and non-availability of anti-
TB drugs were associated with defaulting (50). 
 
Tuberculosis is often considered the disease of the poor and mostly affects people in the 
lower class of the society. This can make it difficult for such patients to pay for associated 
cost during treatment like transportation. The daily attendance to clinic tends to put a strain 
on their finances, thus increasing the risk to defaulting.   
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Lack of privacy in TB clinics can affect the treatment seeking behavior of patients and 
compliance to treatment because of the stigma attached to the disease and its associated 
social problems. Female patients are usually more concerned about privacy than male 
patients and would prefer female health worker to deliver their treatment as they are more 
sympathetic (51).  
 
In most Sub-African countries, there have been an increase in TB case load invariably leading 
to an increase in work load of health workers. This has made the waiting time in clinics 
longer. Patients have to wait for long period of time before collecting their drugs. This has 
greatly influenced defaulting as shown by Chakaya (52).    
 
A study in Senegal in 2006 reported that of the 9,000 new case of TB diagnosed each year, 
nearly 30% of patients do not follow DOTS treatment. Reason for this was long distance to 
health facilities, insufficient time for health workers to listen to patients’ complaints, 
inadequate counseling and information provided by health personnel (53). Inadequate 
counseling, poor service delivery and attitude of health care providers cause patients to 
default (50). 
 
A case control study in Brazil found that most patients default because they do not feel 
comfortable with doctors, blood pressure measurement is not checked and health care 
providers do not give them card indicating next review date (54). 
 
Tuberculosis treatment has been facing some challenges in Nigeria. The structures in the 
health care system, political will by the government for finance sustainability in TB control, 
knowledge about TB and poverty level in the country have greatly influenced defaulting from 
DOTS. The low level of awareness and knowledge of TB has been one of the factors 
responsible for the increasing burden of TB in the country (55). Most patients have no prior 
knowledge about TB, its causative agent and mode of transmission. When such patients are 
placed on treatment, they are more likely to default. A study by Alakpa and Edet reported 
that 69.3% of the population in Lagos were ignorant about TB. This had an influence on 
patient health seeking behavior after onset of treatment to seek health care (56). They found 
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that improper health seeking behavior had adverse impact on case management when 
patients are subsequently placed on DOTS.  
 
The HIV/AIDS epidemic in the country has also influenced defaulting of DOTS. TB patients co-
infected with HIV are more likely do default than non HIV patients. The reason was attributed 
to their health which progressively deteriorate (57). A study showed that default from 
treatment is highest during the continuation phase of treatment and HIV-positive patients 
have twice the risk of defaulting in the intensive phase than HIV-negative patients (58). The 
majority of these patients were in the age bracket 16-45 years. Implying that TB constitute a 
strong economic burden which can cripple the work force of the country.  
 
Amoran et al reviewed the hospital records of TB patients placed on DOTS in Ogun state 
(south west of Nigeria) and found that default was highest in the age group 16-30 years with 
a default rate of 13.9%. The overall default rate was 14.4%. The rate of defaulting was 
significantly higher among patients who returned after previous defaulting and relapse cases 
(59). 
 
A study by Daniel et al reviewed the hospital records of TB patients place on DOTS to identify 
the risk factors associated with defaulting. They compared the demographic and clinical 
characteristics of defaulters and non-defaulters. They found that there was no significant age 
difference between defaulters and non-defaulters, defaulting was highest during the 
continuation phase of treatment and more men defaulted than women (54). They found that 
a strong community based approach with infrastructures for patients´ follow up enhanced 
compliance to treatment, 23% of the patients defaulted compared to another study in a 
similar setting where 44.2% defaulted (60). 
 
1.5    Rationale of the study 
To the best of our knowledge, no study has been done on DOTS assessing the extent of 
defaulting, factors associated with defaulting and the management practice of DOTS in Benin 
City. Most of the studies on defaulting from DOTS were concentrated in the western and 
northern part of Nigeria. Nigeria is a multi-ethnic society with differences in socio economic, 
ethnic composition, religion and culture. There are differences in ethnic and religious make 
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up between Benin City, and western and northern part of the country. Benin City is 
predominantly occupied by the Edo speaking ethnic groups of Bini, Ishan, Etsako, Owan and 
Akoko Edo while the western and northern part of the country are occupied manly by the 
Yorubas, Hausas and Ibos. Predominant religion in Benin City is Christianity whereas the 
Muslims are in majority in the northern part of the country while the west has a mixture of 
Christians and Muslims. 
 
Thus this study was conducted to determine the extent of defaulting from DOTS in Benin City 
and also identify and compare factors influencing defaulting and completion of TB treatment. 
The results will be compared with those done in other parts of the country and elsewhere. 
We expect that the findings from this study will have a significant contribution to the success 
of DOTS in identifying factors for defaulting from DOTS and completion of treatment in Benin 
City and Nigeria in general. 
 
1.6   Research questions 
• What is the magnitude of defaulting among TB patients in Benin City? 
• What are the factors that are associated with defaulting from DOTS? 
1.7     Hypothesis 
• Socio-economic, cultural and religious beliefs have an impact on TB treatment    
defaulting. 
1.8   Objective 
1.8.1 General objective 
• To assess the level of defaulting from DOTS and also identify factors that are   
        associated with defaulting among TB patients in Benin City. 
 
1.8.2  Specific objective 
• To determine the level of defaulting among TB patients in Benin City. 
• To identify the associated risk factors of defaulting among TB patients. 
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2  CHAPTER II:   METHODOLOGY 
2.1  Study area and population 
The study area is Benin City, the capital of Edo State in Southern Nigeria. It has a population 
of 1,147,188 million people (2006 census). It is approximately 25 miles North of the Benin 
river and 200 miles by road East of Lagos, the commercial capital of Nigeria. Benin City is 
homogenous with Edo speaking ethnic groups of Bini, Ishan, Etsako, Owan and Akoko-Edo. 
The Bini speaking people occupy seven out of the eighteen Local Government Areas (LGAs) in 
Edo state. It comprises of three LGAs namely: Oredo, Ikpoba Okha and Egor. The DOTS 
centres used in this study were situated in Egor LGA which has 10 geopolitical wards with a 
population of 229, 681 (61). The predominant occupation in Egor LGA is trading in food stuffs, 
wears and miscellaneous items; farming, civil service and entrepreneurial jobs.   
 
Benin City has four major public health institutions namely: University of Benin Teaching 
Hospital, Central hospital, Stella Obasanjo hospital and Uselu psychiatric hospital. They all 
provide secondary and tertiary health services to inhabitants of Benin City and its environs. It 
is the gate way to the Eastern cities of Onitsha, Enugu, Calabar and Port Harcourt; and to the 
Western cities of Ibadan, Abeokuta and the former political capital Lagos. A major federal 
trunk road runs East-to-West through Benin City, connecting Lagos and the Western states, 
and incorporating the Benin-Sagamu Expressway. It has two major institutions of higher 
learning, University of Benin and Benson Idahosa University renowned for its advancement in 
information technology, entrepreneurship and leadership development. 
The number of functional DOTS centres in Edo State is 102 with 18 functional microscopic 
centres distributed among the 18 local government areas (LGAs) of the state with each LGA 
providing DOTS services. Each LGA in the state has a Tuberculosis and Leprosy (TBL) control 
supervisor responsible for the supervision of TB and leprosy control activities in the 
clinics/health facilities as well as keeping up-to-date of accurate record of TB and leprosy 
control activities in the LGA. They also provide quarterly report to the State TBL control 
officer whose responsibilities among others include collection, collation and analysis of data 
and dissemination of report to Federal Ministry of Health as well as other organizations as 
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appropriate (41).The Tuberculosis and Leprosy Control (TBLC) records for 2011 showed that 
the prevalence of TB in Egor LGA has reduced to 30%, while the defaulting rate is 40% (62)      
The two DOTS centres used for the study were situated in University of Benin Teaching 
Hospital (UBTH) and Egor local government secretariat both in Egor LGA in Benin City. DOTS 
programme started in UBTH August 2006 in the General Outpatient Clinic (GPC) with 2 
doctors and 7 nurses. Egor LGA has 9 DOTS centres, 1 each in UBTH and Egor secretariat and 
7 in private clinics all situated within the 10 wards of the LGA. Most patients within the local 
government come to UBTH and Egor Local Government secretariat because TB drugs are 
given free unlike in the private clinics where they pay some money. Secondly, there are easy 
access roads to these 2 DOTS centres. Thirdly, most patients who are suspected to have TB 
within the local government area are referred here. These necessitated our choice for these 
centres.  
The treatment of TB in Benin City follows the guidelines from the National TB and Leprosy 
Control Programme of Nigeria. Patients suspected to have TB are required to do AFB test. 3 
sputum specimens are collected. TB is diagnosed based on the presence of at least 2 positive 
smear results, if the 3 samples are negative, radiological examination is done using chest X-
ray in addition to clinical findings to ascertain the presence of TB (63). Patients with TB are 
treated under the DOTS programme adopted from WHO guidelines. If TB is confirmed, 
patient is registered in the DOTS clinic where they are given drugs for 8 months. First 2 
months (intensive phase), patients take their medication on a daily basis in the DOTS centre 
in the presence of a designated health worker after which they collect their medication once 
monthly for 6 months (continuation phase). The recommended drug regimen for the 
intensive phase is isoniazid, rifampicin, ethambutol and pyrazinamide. In the continuation 
phase ethambutol and isoniazid are given. For retreatment cases, streptomycin is given for 3 
months in the intensive phase in addition to isoniazid, pyrazinamide and rifampicin. During 
the course of the treatment, patients are required to produce 2 sputum samples for AFB test 
at the end of 2nd, 5th and 7th month to ascertain sputum conversion. If at the end of the 5th 
month sputum smear result is still positive, treatment is discontinued, patient is placed on 
category 2 regimen. 
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Figure 3 Shows map of Nigeria and the study centres in Benin City 
 
2.2   Study design 
This was a retrospective case control study. This study design was chosen because we are 
looking back in time to determine if some possible exposures or variables had influence on TB 
treatment outcome. We can simultaneously examine these variables and see if there is an 
association between them and treatment outcome. Secondly, a retrospective case control 
study takes less time to complete compared to other studies because our outcome of 
interest has already occurred (64). 
All TB patients placed on DOTS from August 2006 to December 2010 were included in the 
study. Patients who defaulted formed the cases, while those who completed treatment made 
up the control group. Information about TB patients was collected from hospital records, 
followed by house to house interviews. TB treatment details collected from the interview 
session with patients were corroborated with hospital records to minimize recall bias which is 
a short coming in this type of study (64). All other information pertaining to patients related 
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factors and service providers factors could not be verified from hospital records, thus recall 
bias cannot be totally eliminated. 
2.3  Sampling method 
2.3.1 Sample size estimation 
The sample size of the study population was calculated using the formula below: 
n = Z
2 
x p(1-p)/E
2 
(65) 
Where Z = 1.96,   P = rate of defaulting, E =margin of error, n = sample size  
Due to the absence of previous studies on defaulting from DOTS in Benin City, we assume a 
default rate of 23% from a Nigerian study (57), 95% CI (Z =1.96), 5% margin of error we got a                                                                             
sample size of 272. However, we were able to interview 262 patients (96.3%) of the targeted 
sample size comprising of 99 defaulters and 163 non-defaulters. 
2.3.2 Inclusion and exclusion criteria 
2.3.2.1 Inclusion criteria 
1) TB patients who live within Benin City. 2) All TB patients registered in the 2 DOTS centres 
from August 2006 to December 2010. 3) Patients who defaulted after being on treatment for 
at least 4 weeks and whose treatment were interrupted for more than 8 weeks.  
2.3.2.2 Exclusion criteria 
1) TB patients who live outside Benin City. 2) Patients who defaulted after being on 
treatment for less than 4 weeks. 3) Patients whose contact information were incomplete. 4) 
Patients who died, transferred to other DOTS centres or had treatment failure. 
2.3.3 Sampling procedure 
We reviewed the TB register in the 2 study centres and compared it with patients’ treatment 
cards. This was done to ascertain the actual number of patients. There were missing cards 
that could not be accounted for after comparing TB register with individual treatment cards. 
We were able to identify 1,253 patients from the treatment cards. Patients who died 
53(4.2%) and transferred out 71(5.7%) were excluded from the study. 
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The remaining 1,129 patients comprised of both patients who completed treatment and 
defaulted. From this sample size, 14(1.2%) died, 314(27.8%) incomplete contact information, 
38(3.4%) resided outside Benin City and 41(3.6%) defaulted less than 4 weeks were all 
excluded. Finally, we got 722(63.9%) of the patients who made up the study population out 
of which 550(76.2%) completed treatment and 172(23.8%) defaulted. From our target 
sample size of 272, we were able to get 262 patients, 163(29.6%) from complete treatment 
group and 99(57.6%) from defaulters’ group (see figure 4 below). 
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                                                                        14  Died     
                                                                      314  Incomplete contact information 
                                              38   Resided outside Benin City   
                                             41   Defaulted less than 4 weeks 
 
 
      
 
              30   Relocated 
                                                      25  Difficult to trace 
                 18   Non-responders 
                   Interviewed            
 
Figure 4  Sampling technique of TB patients placed on DOTS in the 2 study centres in Benin 
City 
                               Source population 
                       TB patients placed on DOTS 
                                        1,253 
                 1,129 
       Non-defaulters    
                 and 
         Defaulters        
 
    53 
   Died 
      71 
     T/out 
 
Study population 
              722 
         550  
 Non-defaulters  
      (Control) 
      172 
 Defaulters 
   (Cases) 
        99     
     163   
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2.4  Data collection 
After identification of TB patients from the treatment cards, information pertaining to 
patients’ socio-demographic characteristics, type of regimen, sputum smear/X-ray results, 
date of diagnosis, date treatment started and treatment outcome were entered into the 
investigator’s collection form. We used a semi-structured questionnaire for collecting data 
from the study population (appendix 3). The questionnaire had 5 parts: socio-demographic 
information; TB treatment details; patients’ related factors; perception, attitude and beliefs 
of TB; and service provider factors. The questionnaire was pretested in one of the study 
centres. 10 patients were randomly selected (7 complete treatment and 3 defaulters) as part 
of practical exercise to determine the quality of the questionnaire. After pretesting, we 
reviewed it and added some questions.   
Data collectors were recruited from the local community to enable us to have easy access to 
study participants. The principal investigator gave 2 days training about the study proposal to 
the data collectors. The questionnaire was studied thoroughly by the data collectors to have 
good grasp of its content and areas that were not clear to them were explained by the 
principal investigator. Patients were contacted on phone to schedule an appointment for 
interview. Before the commencement of the interview, they were informed of the 
significance of the study, what it entails to participate, information required from them and 
assurance of confidentiality that information collected will not be connected to them. They 
were also informed that participation is voluntary, that they can withdraw at any time 
without having any consequences on them accessing health care. After giving these 
information, each patient was asked to sign the consent form (appendix 2) in the presence of 
a witness. The principal investigator was in constant communication with the data collectors 
on a daily basis. Data collected from patients were entered into Excel spread sheet in the 
computer. For the TB treatment details information collected from patients on the field; date 
of diagnosis, date treatment started, type of drug regimen used, were all corroborated with 
the hospital records before entry into the computer.    
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2.5  Definition of variables  
2.5.1 Dependent (outcome) variables 
•    Defaulter: A patient is defined as a defaulter if he or she has stopped taking anti-TB  
   medication for a period of 8 consecutive weeks after being on treatment for at least  
   4 weeks 
• Non defaulter: A patients who completed the maximum duration of treatment 
  without stopping for a period of 6 or 8 months but has not be confirmed cured by  
  laboratory test.      
 
2.5.2   Independent variable   
Table 5 Shows the independent variables used as the explanatory variables for the outcome 
variables. 
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Table  5 Definition of variables used in explaining the outcome variables 
      Variable               Operational definition 
      Age   Age at last birthday in years 
      Gender   Male or female 
      Education   Level of education attained expressed as  
  primary, secondary or tertiary 
      Occupation   Work done as a means of livelihood (farming,  
  business or civil servant) 
     Marital status   Married or single 
     Monthly Income   Money earned from work/business per  
  Month in Naira (Nigerian currency) 
     Family size   Number of people in a household 
     Transport cost   Money spent on transportation to and from  
  clinic in Naira 
     Concomitant drug use    Use of other medications alongside TB drugs 
     Waiting time   Time spent at the clinic before collecting  
  drugs 
     Bearer of transport cost   Person responsible for transportation cost  
  during treatment. 
     Privacy   Suitable environment for interaction  
  between care provider and patient  
    TB knowledge   Awareness of the outcome of not completing  
  treatment 
   Travelling during treatment   Travelling out of community during the course  
  of treatment 
  TB treatment counseling   Number of times health worker counsel    
  patient about TB. 
  TB education   Health workers educating patients on mode of 
  transmission and causes of TB   
 
 
2.6   Data management and analysis 
 
2.6.1  Data management 
 
The data collected from questionnaire were checked before entry into Excel spread sheet. 
Information that was not properly entered in the questionnaire was clarified before entry. 
After entry all information into the system, we cross checked each information entered in the 
system with the questionnaire to ensure consistency of information. Data was exported into 
SPSS version 18 for analysis.  Data was screened and cleaned using frequency and distribution 
checks to look into the range of values, identify missing data and miscoded data. 
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2.6.2 Data analysis 
Some of the independent variables to be used in the analysis were re-categorized and 
recoded in order to have adequate number of observations for the analysis. Categorical 
variables that were re-categorized and recoded include: education three groups 
(secondary/others coded ‘1’, no education/primary coded ‘2’, and tertiary coded ‘3’), 
occupation four groups (business coded ‘1’, student/unemployed coded ‘2’, farmers/others 
coded ‘3’ and civil servants/professional coded ‘4’), marital status two groups (single coded 
‘1’, married coded ‘2’), monthly income two groups (< 18,000 coded 1, ≥ 18,000 coded ‘2’).  
Transport cost had two groups with <200coded ‘1’, ≥ 200 coded ‘2’). Sex was coded ‘1’ for 
female and ‘2’ for male. 
 
For the continuous variable re-categorized and recoded age had four groups (0-15 years 
coded ‘1,’ 16-31 years coded ‘2,’ 32-47 years coded ‘3’ and ≥ 48 years coded ‘4’). Frequency 
of counseling about TB treatment, three groups with (each visit coded ‘1’, 1st visit only coded 
‘2’ and occasionally coded ‘3’). Waiting time at the clinic three groups (< 30 minutes coded 
‘1’, 1-2 hours coded ‘2’ and > 2 hours coded ‘3’). The other exposure variables used in the 
analysis; TB knowledge, privacy provided by health care workers and bearer of transportation 
cost had only two categories each coded ‘1’ and ‘2’ respectively. All variables coded ‘1’ were 
used as the reference category except age (16-31 years was used as the reference).Chi square 
test was used to determine the proportions of independent exposure variables within the 
outcome variable and also to determine the association of some independent variables not 
included in the logistic regression analysis with the outcome variable. Fisher exact test was 
used if any cell had expected cell count < 5, Yates’ Continuity Corrected P values were used 
for categorical variables in a 2 by 2 table which serves as a compensation for the 
overestimation of Chi square value. A two-sided P value of 0.05 was considered statistically 
significant relationship between the independent variable and outcome variable. 
 
Univariate association between independent variable and outcome variable was assessed 
using binary logistic regression with the strength of association evaluated using odds ratio 
(OR) and 95% confidence interval (CI). This enabled us to compare the two groups in the 
outcome variable (defaulters and non-defaulters). All candidate variables were included at 
once in the multivariate regression analysis to control for confounding effects. A value of P ≤ 
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0.25 from the univariate analysis was considered as a basis for inclusion into the multivariate 
analysis. We also carried out collinearity test to check for correlation between the 
independent variables before inclusion in the multivariate regression model.  
 
Thus combination of the following criteria was used in selecting our exposure variables: 
• P  value less than or equal to 0.25 
• Collinearity coefficient of variables less than 0.6 was considered an acceptable value. 
 
2.7  Ethical clearance 
Ethical clearance for the research work was obtained from the Regional Ethical Committee of 
Bio-Medical Research in Norway (REK, Sør-øst) and also from the Ethics and Research 
Committee of University of Benin Teaching Hospital. 
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3    CHAPTER III:  RESULTS 
 
In this study, 1,253 TB patients were registered on DOTS in the two study centres. Using the 
inclusion and exclusion criteria, 722 patients comprising of 172 (23.8%) defaulters and 550 
(76.2%) non-defaulters made up the study population. From this number, 262 patients 
comprising of 99 defaulters and 163 non-defaulters were interviewed. We present the results 
based on the five major stratifications used in the questionnaire. They include: Socio-
demographic characteristics, TB treatment details, patients related factors, patients’ 
perceptions, attitude and beliefs of TB, and service provider factors. 
 
3.1   Socio-demographic characteristics of study population 
3.1.1 Baseline characteristics 
From the 262 patients that were recruited for the study,144(55%) were males while females 
were 118(45%). The age distribution showed majority of the respondents were within the age 
group 16-31 109(41.6%) and 32-47 86(32.8%). About half of the participants had secondary 
education 130(49.6%) while the least educated (primary) was 42(16%). More than half of the 
study participants were married 141(53.8%) while 121 (46.2%) were single. Majority of the 
patients had family sizes 5-8 144(55.2%) and 1-4 99(37.9%) respectively. A larger number of 
participants had their personal business 116(44.3%) compared to those who were employed 
as civil servants 38(14.5%) and farmers 25 (9.5%).The number of unemployed/students was 
83(37.1%). Majority of the study participants were Christians 255(97.3%), only 3(1.2%) and 2 
(0.8%) were Muslims and traditional worshippers respectively. The majority of the 
respondents were from the Bini ethnic group 168(64.1%), the other ethnic groups together 
accounted for 94(35.9%) of the study population. Monthly income among those who gave 
the information showed that 73(60.8%) were earning less than 18,000 Naira while 47(39.2%) 
were earning 18,000 Naira and above. Table 7 gives an overview of the socio-demographic 
characteristics of the study participants in Benin City. 
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Table 7 Shows socio-demographic characteristics of the treatment group in Benin City 
(N=262) 
  Variable  Count        Percentage (%) 
 Age   
  0-15                 13                 5.0 
 16-31               109                 41.6 
 32-47                 86               32.8 
 ≥48                 54               20.6  
  Sex   
  Male               144               55.0 
  Female               118               45.0 
  Marital status   
  Married               141               53.8  
  Single               121               46.2 
  Occupation   
  Single/unemployed                83               31.7    
  Farmer/others                25                 9.5 
  Business               116                44.3 
  Civil servants/professional                38               14.5 
   Family size†   
   1-4                99                    37.9 
   5-8              144                 55.2 
   >8                 18                 6.9 
   Education   
   No formal education 
   /primary  
               42               16.0 
   Secondary/others              130                49.6 
   Tertiary                90               34.4 
   Monthly income*   
    <18,000 Naira1                73               60.8 
    ≥18,000 Naira                47                39.2 
    Religion   
    Christian             255               97.3 
    Muslim                 3                 1.2 
    Traditional worshipper                 2                 0.8 
    Ethnicity   
    Bini             168               64.1  
    Ishan               26                 9.9 
    Igbo               29               11.1 
   Others               39                                                    14.9 
*142(54.2%) missing cases because income does not apply to all patients and some refused  
to indicate their income.    †1 (0.3%) missing case 
 
___________________________ 
1
1 US dollar≡ 158 Nigerian Naira as at the time of writing   
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Figure 5 Bar graph showing age group distribution among treatment group. 
 
 
The age distribution of the treatment group showed majority of the patients were within the 
age group 16-47 years, 73 (73.8%) for patients who defaulted and 122 (74.9%) for non-
defaulters (figure 5 above). 
 
Figure 6  Bar graph showing distribution by gender of defaulters and non-defaulters 
among the treatment group 
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The figure above shows that males 67 (67.7%) were the majority among defaulters compared 
to females 32 (32.3%). On the other hand, more than half of the patients who completed 
treatment were female 86 (52.8%) while male accounted for 77 (47.2%) (Figure 6 above). 
 
Figure 7  Pie chart showing marital status distribution among defaulters in the treatment 
group 
 
 
Majority of the patients that defaulted were married 64 (64.6%) while 35 (35.5%) were single.  
(Figure 7 above). 
Figure 8 Pie chart showing marital status distribution among non-defaulters in the 
treatment group  
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On the other hand, among patients who completed treatment, the majority were singles 86 
(52.8%) compared to 77 (47.2%) who were married (figure 8 above).  
 
3.1.2   Socio-demographic associated factors 
Univariate analysis of the socio-demographic factors indicated that sex had a significant 
association (P=0.001, OR=2.34) with defaulting. There was also a significant association 
between marital status and defaulting (P=0.006, OR=2.04). Age (P=0.616), education 
(P=0.414), occupation (P=0.090), monthly income (P=0.542, OR=1.28) and family size 
(P=0.373) did not have any significant association with defaulting (table 8). 
 
Table 8 Shows univariate analysis of association between  socio-demographic factors an 
and treatment group  
Factor Label Non-
defaulter 
Defaulter OR 95%CI P-value 
Age  16-31  72  37 1.0  0.616** 
 0-15  7   6 1.67 (0.52,5.32)  
 32-47  50  36 1.40 (0.78,2.51)  
 ≥48  34  20 1.15        (0.58,2.26)  
Sex Female 86  32  1.0  0.001* 
 Male  77  67 2.34 (1.39,3.94)     
Education     Secondary/others  80               50 1.0  0.414 
 No 
education/primary 
 23  19 1.32  (0.65,2.67)  
 Tertiary  60  30 0.80 (0.46,1.41)  
Occupation    Business  65  51 1.0  0.090 
 Student/unemployed  51   32 0.80 (0.45,1.42)  
 Farmer/others  17  8 0.60 (0.24,1.50)  
 Civil 
servant/professional 
 30  8 0.34 (0.14,0.81)  
Marital 
status 
Single 
Married 
 86 
 77 
35 
64 
1.0 
2.04 
 
(1.22,3.42) 
0.006* 
       
Monthly         
income 
< 18,000 
≥ 18,000 
 52 
 31 
21 
16 
1.0 
1.28 
 
(0.58,2.81) 
0.542 
       
Family size     5-8  87 57 1.0  0.373 
 1-4  62 37 0.91 (0.54,1.54)  
 >8  14 4 0.44 (0.14,1.39)  
**Fisher exact test     *Significant at P≤0.05OR =Odds ratio  CI =Confidence interval 
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3.2   Patient related factors 
3.2.1  Baseline characteristics 
Transport cost to and from the clinic; person responsible for transportation cost, aware of 
the consequences of not completing treatment (TB knowledge); travelled out of community 
during treatment, the use of other medications alongside TB drugs; type of support received 
during treatment and the consumption of other substances were assessed in relation to 
defaulters and non-defaulters. Reasons for discontinuing treatment and the phase at which 
treatment was stopped for defaulters were also assessed. More than half of the defaulters 
58(58.6%) travelled outside the community during treatment while only 24 (14.7%) of non-
defaulters did travelled outside community. A larger number of defaulters 91 (91.9%) and 
non-defaulters 156 (95.7%) were aware of the consequences of not completing treatment. 
Only 7 (4.3%) of non-defaulters and 8 (8.1%) of defaulters were ignorant of the consequences 
of not completing treatment. For transportation cost, most of the defaulters 74 (74.8%) spent 
around 200 Naira on transportation while only 25 (25.3%) spent 200 Naira and above. For 
non-defaulters, majority 133(81.6%) admitted spending within 200 Naira while 30 (18.4%) 
spent 200 Naira and above. Majority of patients that defaulted 56(56.6%) were sole provider 
of transportation cost, 43 (43.4%) had support from others. For patients who completed 
treatment, majority 92 (56.4%) were responsible for the cost of transportation compared to 
71 (43.6%) who had support.  
 
The reasons for defaulting include: feeling better 35 (35.4%),long distance to health facility25 
(25.3%), lack of money10 (10.1%), medication side effects5 (5.1%), condition worsened i.e. 
did not improve with the use of TB drugs 4 (4%), thought hospital treatment will not cure the 
disease 2 (2%) and maternal leave 1(1.0%). Patient relocating to other areas for greener 
pastures and business trips, family re-union, funeral ceremony in another community outside 
Benin City, seeking help from a spiritualist and herbalist were included as other reasons given 
by 28(28.3%) of patients (table 9). Some patients gave multiple reasons for defaulting. 
 
The majority 59(59.6%) defaulted in the continuation phase of treatment, while 40(40.4%) 
defaulted in the intensive phase. Regarding the consequences of defaulting, 29(29.3%) of 
defaulters said the organism causing TB becomes resistant to drugs, 28(28.3%) infect those 
around, 4(4%) death and 28(28.3%) a combination of the three. Among defaulters, 5 (5.1%) 
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admitted consuming tobacco, 22(22.2%) alcohol, 37(37.4%) honey and 44(44.4%) Bitter kola. 
For non-defaulters, 46 (28.2%) took honey, 31 (19.0%) Bitter kola, 6 (3.7%) tobacco and 20 
(12.3%) alcohol.  
 
Table 9   Shows reasons for stopping treatment (Defaulters)[N=99] 
            Reasons               Number            Percentage 
Felt better                   35                   35.4 
Long distance to health 
facility 
                  25                   25.3 
Lack of money                   10                   10.1 
Medication side effects                    5                     5.1 
Condition did not improve                    4                     4.0 
Thought hospital treatment 
will not cure the disease 
                   2                      2.0 
Maternity leave                    1                      1.0 
Others                   28                    28.3  
*Multiple response 
 
From the 262 patients that made up the treatment group, 249 patients provided information 
regarding support received from family members and friends during treatment. Only 1 (0.4%) 
of defaulter admitted having no support, the others received support in form of helping in 
prayers 88 (35.3%), financial assistance 72 (28.9%), a reminder to take their medications 57 
(22.9%) and helping in household chores 60 (24.1%). Majority of Patients that completed 
treatment also had support in prayers 139 (55.8%), financial assistance 119 (47.8%), reminder 
to take their medications 118 (47.4%) and helping in household chores 99 (39.8%) (table10). 
Multiple response in relation to support rendered during treatment were given. 
 
Table 10 Shows  support rendered by family members/friends among the treatment group  
(N=249) 
                   Support*              Non-defaulter Defaulter 
     Count             % Count           % 
Helping in prayers        139            55.8            88          35.3 
Supported financially        119            47.8            72          28.9 
Reminder to take drugs        118            47.4            57          22.9 
Helping in household chores          99            39.8            60          24.1 
*Multiple response 
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3.2.2  Patient related factors and its association with treatment group 
Regarding patients related factors using univariate logistic regression, only five independent 
variables or explanatory variables were considered. The reason being that these variables 
have only two categories each and also have adequate number of observations that is 
suitable for the analysis. Among patient related factors, a significant association was 
observed between defaulting and travelling outside of locality during treatment (P<0.001, 
OR= 4.09). Bearer of transportation cost, awareness of the consequences of not completing 
treatment (TB knowledge) and the use of other medications with TB drugs did not have 
significant association with defaulting (P>0.05) ( table11) 
 
Table 11 Shows univariate analysis of association between patient related factors and 
treatment group 
  Factor  Label Non-defaulter Defaulter   OR 
 
95%CI P-value 
Transport cost < 200         133        74  1.0  0.189 
 ≥ 200           30        25  1.50 (0.82, 2.74)     
Bearer of 
transport cost 
 
Self 
 
          82 
 
       56 
 
1.0 
  
0.984 
 Others           71        43  0.99 (0.60, 1.65)  
TB knowledge Yes          156          91  1.0  0.208 
  No              7          8  1.96 (0.69, 5.58)  
Travelled 
outside locality 
during 
treatment 
 
 No 
 
         139       
 
       58  
 
 1.0 
  
<0.001* 
 
 
Yes            24        41   4.09 (2.27, 7.38))  
Use of other 
drugs with TB 
drugs 
 No            72        36   1.0  0.192 
  Yes            88        62   1.41 (0.84, 2.36)  
*Significant at P ≤ 0.05 
 
From the substances consumed by the respondents, only the use of Bitter kola had a 
significant association with defaulting (P<0.001), others (P>0.05) showed no significant 
relationship with defaulting (table 12). The P values presented above were for Yates’ 
Continuity Correction for 2 by 2 table only not Pearson Chi square values because the 
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continuity correction compensates for the overestimate of Chi square value when used in a 2 
by 2 table. 
Table 12  Shows association between Substances consumed by respondents and treatment 
group     
 Substances++       Non-defaulter         Defaulter         P-value† 
    Count % Count %  
Tobacco       6    3.7   5 5.1             0.752** 
Alcohol      20  12.3 22 22.2           0.051 
Bitter kola      31   19.0 44 44.4         <0.001* 
Honey      46  28.2 37 37.4           0.159 
++Multiple response *Significant at P ≤ 0.05 †P values based on Yates’ Continuity Correction 
 **Fisher exact test      
 
Regarding type of family support received during treatment, there was a significant 
difference between defaulters and non-defaulters with regards to reminder to take TB 
medications (P=0.02). There was no significant difference between defaulters and non-
defaulters (P>0.05) in relation to financial support, helping in household chores and prayers. 
 
3.3     Service provider factors 
3.3.1   Baseline characteristics 
Here we assessed how patients were managed by health care providers in the course of TB 
treatment. Most patients who defaulted 72(72.7%) admitted that they were not accorded 
privacy during treatment, 27 (27.3%) claimed to have been given privacy. For patients who 
completed treatment, 86 (52.8%) admitted they were not given privacy while 77 (47.2%) 
were given privacy by health care providers. 
 
The frequency of counseling on the need to complete treatment indicated that most patients 
who defaulted 61 (61.6%)in treatment were counseled on each visit, 36 (36.4%) on the first 
visit only and 2(2%) occasionally. For non-defaulters, majority 89 (54.6%) admitted being 
counseled on each visit to the clinic, 27 (16.6%) occasionally and 47 (28.8%) on the first visit 
only. 
 
The waiting time at the clinic before drug administration showed that most defaulters waited 
less than half an hour before collecting  drugs, 34 (34.3%) between 1-2 hours and only 4 
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(4.0%) more than 2 hours. Most patients that completed treatment 102 (62.6%) waited half 
an hour before collecting their medications, 51 (31.3%) between 1-2 hours and 10 (6.1%) 
more than 2 hours. 
 
Majority of the defaulters 95 (96.0%) admitted that they were educated by health providers 
regarding the cause and mode of transmission of TB, 4 (4.0%) indicated they were not given 
these information. For patients who completed treatment, majority 157 (96.3%) admitted 
being educated by health providers and 6 (3.7%) said they were not educated. 
 
3.3.2  Service provider factors and its association with treatment group 
Privacy provided in the clinic had a significant association with defaulting (P=0.002, OR=2.39).  
There was a significant difference in frequency of counseling between defaulters and non-
defaulters, (P=0.009,).  Regarding waiting time in the clinic, the difference between 
defaulters and non-defaulters was not significant (P=0.710). There was no significant 
difference between patients who were educated (96.0% vs.96.3%) and not educated (4.0% 
vs.3.7%) about TB for defaulters and non-defaulters respectively (P=0.883, OR=1.10) (table 
13).   
 
Table 13  Shows univariate analysis of the association between service provider factors and 
treatment group. 
Factor Label   Non 
Defaulter 
Defaulter OR 95%CI P-value 
Frequency of TB 
treatment 
counseling 
 
Each visit  
 
89 
 
61 
 
1.0 
  
0.009* 
 First visit only 47 36 1.12 (0.65, 1.92)  
 Occasionally 27 2 0.11 (0.03, 0.47)  
Privacy provided Yes 77 27 1.0  0.002* 
 No 86 72 2.39 (1.39, 4.09)  
Waiting time <30 minutes 102 61 1.0   
 1-2 hours 51 34 1.12 (0.65, 1.91) 0.710 
 >2 hours 10 4 0.67 (0.20, 2.23)  
TB education Yes 157 95 1.0  1.000** 
 No 6 4 1.10 (0.30, 4.01)  
*Significant at P ≤0.05   **Fisher exact test 
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3.4   Tuberculosis treatment information 
3.4.1 Baseline characteristics 
The TB treatment details include: time gap between first experience of symptoms and 
reporting to the clinic, year of diagnosis, type of diagnosis, date treatment started and  
response on first experience of TB symptoms.  
 
Majority of defaulters 64(64.6%) had a time gap of 1-2 months between first experience of 
symptoms and reporting to the hospital compared to 19(19.2%) and 14(14.1%) patients who 
had  a time gap of  less than one month and more than two months respectively. The 
majority of patients that completed treatment 102(62.6%) also had a time gap of 1-2 months 
before reporting to the hospital, 37(22.7%) less than one month and 17(10.4%) more than 
two months (table 14) 
 
Table 14  Shows Time gap between emergence of symptoms and reporting to clinic 
 
 
 
 
 
 
Regarding the year of diagnosis, there was an upward trend in defaulting rate over the years 
from 2006 to 2009 (keeping in mind that we excluded some patients who did not meet the 
inclusion criteria and those who did not remember the year of diagnosis). The trend was    
(3.0%) in 2006 to 29(29.3%) in 2009, then a decline to 16(16.2%) in 2010 (figure 12). 
 
 
 
 
 
 
 
 
Time gap               Non-defaulter             Defaulter 
    Count        %    Count      % 
 Can’t remember        7         4.3        2       2 
  < 1 month      37       22.7      19      19.2 
  1-2 months      102       62.6      64      64.6 
  >2 months       17       10.4      14      14.1 
  Total      163       100      99      100 
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Figure 12 Bar chart shows defaulter rate among treatment group between 2006-2010 
 
 
For patients who completed treatment, there was an increase from 11(6.7%) in 2006 to 
56(34.4%) in 2007, with subsequent decline from 43(26.4%) in 2008 to 14(8.6%) in 2010.  
 
A similar pattern for date treatment started was also observed for defaulters. There was an 
increase from 9(5.8%) in 2006 to 56(36.4%) in 2007 with a subsequent decline from 43(27.9%) 
in 2008 to 16(10.4%) in 2010 (table 16). We had 11(4.2%) of missing cases of no response of 
the date treatment started (different from patients who could not remember the date 
treatment started). 
 
About half of the patients who completed treatment 82(50.3%) did both sputum test and X-
ray examination while 31(19.0%) and 50(30.7%) did only X-ray and sputum test respectively. 
For patients that defaulted, 45(45.5%) did both X-ray and sputum tests, while 14(14.1%) and 
40(40.4%) did only X-ray and sputum test respectively. 
 
The actions taken on first experience of TB symptoms showed that majority of the defaulters 
56(56.6%) went to the hospital for treatment, 30(30.3%) used the services of pharmacy, 
29(29.3%) patronized patent chemist store, 11(11.1%) went to traditional healers and 
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24(24.2%) used drugs on the basis of self-medications. A larger number of non-defaulters 
72(44.4%) went to the hospital for treatment while 42(25.8%) used the services of pharmacy. 
 
3.4.2   Tuberculosis treatment associated factors 
Using Chi square test, we found that there was a significant association between year of 
diagnosis and defaulting(X
2
=17.14, P=0.004). The date treatment started did not show a 
significant association with defaulting (Fisher exact text, P=1.000). Type of diagnosis(X
2
=2.85, 
P=0.241) and the time gap between onset of symptoms and reporting to the clinic for 
treatment (Fisher exact text, P=1.00) had no significant association with defaulting (table 15) 
 
Table 15 Shows association between TB treatment details and treatment group 
*Significant at p ≤ 0.05
++
11(4.2%) missing information 
+
Fisher exact test was done because  
   of violation of Chi square assumptions 
 
Using Chi square analysis also to test for the association between the actions taken on first 
experience of TB symptoms and treatment group, we found no significant association with 
defaulting P > 0.05 (table 16). 
 
Table 16  Shows association between the actions taken on experiencing TB symptoms and     
treatment group. 
Action taken*    Non 
defaulter 
Defaulter P-value† 
 Count % Count %  
Self-Medication 47 38.8 24 24.2 0.504 
Use traditional healer 9 5.5 11 11.1 0.158 
Patronized Patent  
Medicine 
57 35 29 29.3 0.416 
Went to Pharmacy 42 25.8 30 30.3 0.513 
Went to hospital 72 44.2 56 56.6 0.069 
* Multiple response    
†
 P values based on Yates’ Continuity Corrections 
 
  TB treatment details 
Non 
defaulter                          
 
Defaulter         ᵪ2 
 
  P-value 
   Time gap 163       99                +         1.000 
   Year of diagnosis 163       99               17.14         0.004*  
   Type of diagnosis 163       99                2.85         0.241 
   Date treatment started++ 154       97                +          1.000               
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3.5 Perceptions, beliefs and attitude of TB among treatment group 
3.5.1 Baseline characteristics 
We determined patients’ perceptions, attitude and religious beliefs of TB in their community. 
We also assessed patients’ perceived cause of their TB and determined whether or not family 
and friends were aware of their TB. 
 
Most of the patients that defaulted 95(96.0%) indicated that family and friends knew they 
had TB, 4(4.0%) did not inform family members. 155(95.1%) of patients who completed 
treatment indicated that family and friend were aware of their TB condition and 8(4.9%) did 
not inform family members (table 17).  
 
Table 17 Shows  Family/friends aware of TB condition 
 Non-defaulters Defaulters 
 Count % Count % 
Yes 155 95.1 95 96.0 
No 8 4.9 4 4.0 
Total 163 100.0 99 100.0 
 
About half of defaulters 46(46.5%) indicated that TB can be caused by witchcraft/spiritual 
means, 3(3.0%) punishment for dishonest deeds, 24(24.2%) hereditary, 5(5.1%) can be cured 
by prayers and 33(33.3%) admitted they do not know. 
 
59(36.2%) of non-defaulters admitted TB can be caused by witchcraft/spiritual means, 
58(35.6%) said they do not know, 11(6.7%) hereditary, 14(8.6%) can be cured by prayers and 
8(4.9%) punishment for dishonest deeds. 
 
22(22.2%) of defaulters had the perception that TB can be cured by traditional means, 
32(32.3%) see TB has a deadly disease that should be feared, 10(10.1%) admitted that TB can 
be cured by orthodox drugs and 7(7.1%) TB is associated with stigma. 
 
43(26.4%) of non-defaulters admitted TB is a deadly disease, 33(20.2%) TB is associated with 
stigma, 25(15.3%) can be cured by traditional means and 30(18.4%) can be treated with 
orthodox medicines.  
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For patients perceived causes of their TB, 38(38.4%) of defaulters admitted it was caused by 
spiritual attack, 37(37.4%) overcrowding, 21(21.2%) stress and 17(17.2%) malnutrition.  
For non-defaulters, 57(35.0%) said their TB was caused by overcrowding, 34(20.9%) 
malnutrition, 27(16.6%) spiritual attack and 20(12.3%) stress (table 18). 
 
Table 18 Shows Perceived causes of TB by respondents 
    Response*            Non-defaulter               Defaulter 
 Count         %  Count        % 
  Malnutrition     34        20.9    17     17.2 
  Poor hygiene    11          6.7    11                       11.1 
  Overcrowding    57          35.0 37     37.4 
  Alcohol intake     14          8.6    12     12.1 
  Tobacco intake      4          2.5      5       5.1  
  Stress    20        12.3     21      21.2 
  Spiritual attack    27        16.6    38      38.4 
*Multiple response 
 
3.5.2   Perception, beliefs and attitude of TB and its association with the treatment group 
The belief that TB is hereditary showed a significant association with defaulting (P<0.001) 
(table 19) 
 
Table 19  Association between beliefs and perceptions of TB among treatment group 
Response++ Non-defaulter N (%) Defaulter N (%)  P-value† 
Caused by spiritual 
means/witchcraft  
 
59(36.2) 
 
          46(46.5) 
 
              0.130 
Punishment for 
dishonest deeds 
 
    8(4.9)      
 
              3(3.0) 
 
              0.542** 
Hereditary   11(6.7)           24(24.2)              <0.001* 
Can be cured by 
prayers  
 
  14(8.6) 
 
             5(5.1) 
 
              0.410   
++Multiple response +P values are for Yates’ Continuity Corrections *Significant at P≤0.05   
** Fisher exact test 
 
For patients’ perceived cause of their TB, there was a significant difference between 
defaulters and non-defaulters (38.4% vs.16.6%) in terms of spiritual attack with(P <0.001) 
showing a significant association with defaulting (table 20). 
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Table 20 Association between perceived causes of TB and treatment group 
Response++   Non-defaulter        Defaulter          P-value† 
   Count      %  Count        %  
Malnutrition     34     20.9    17       17.2           0.569 
Poor hygiene     11       6.7    11       11.1           0.315 
Overcrowding 
 
    57     35.0    37       37.4           0.794 
Alcohol intake  
    14 
 
     8.6 
 
   12 
 
      12.1 
 
          0.475 
Tobacco intake  
      4 
 
     2.5 
 
    5 
 
        5.1 
 
          0.442** 
Stress     20     12.3    21         21.2           0.079 
Spiritual attack     27     16.6    38        38.4         <0.001* 
++Multiple response *Significant P≤0.05  
†
P values are for Yates’ Continuity Corrections 
** Fisher exact test 
 
3.6    Determinant factors of TB treatment defaulting 
3.6.1 Multivariate logistic regression analysis of determinant factors of TB treatment  
defaulting 
We selected our variables for the multivariate logistic regression analysis based on a P value 
of ≤ 0.25 from the univariate analysis bearing in mind each of the reference group. Male sex, 
occupation(student/unemployed, farmer/others and civil servants/professional), marital 
status(married), transport cost ≥ 200, no TB knowledge, travelled out of locality during 
treatment, the use of concomitant drug with TB drugs, counseling frequency (first visit only 
and  occasionally) and no privacy fulfilled the criteria for inclusion in the multivariate analysis. 
The strength of association of these determinants factors was determined by the odds ratio, 
with a P value ≤ 0.05 indicating a significant association with defaulting. Table 21 below 
presents the results of the multivariate logistic regression analysis. 
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Table  21 Multivariate logistic regression analysis of determinant factors of  TB    
treatment defaulting 
Factor          AOR    95%CI           P-value 
Male           3.05 (1.60, 5.80)            0.001* 
Student/unemployed           1.36 (0.56, 3.30)            0.495 
Farmer/others           0.55 (0.17, 1.77)            0.316   
Civil servant/professional           0.24 (0.08, 0.70)            0.009* 
Married           3.06 (1.34, 6.99)            0.008* 
Transport cost ≥ 200           1.21 (0.57, 2.54)            0.622 
No TB knowledge           1.91 (0.48, 7.62)            0.357  
Travelled outside locality 
during treatment 
 
          6.87 
 
(3.19, 14.80) 
 
         <0.001* 
Concomitant drug use 
with TB drugs 
 
          1.95 
 
(1.02, 3.73) 
 
           0.045* 
Counseled on first visit 
only  
 
          0.87 
 
(0.44, 1.71) 
 
           0.680 
Counseled occassionally           0.05 (0.01, 0.28)           <0.001* 
No privacy given           1.93 (0.99, 3.71)            0.051 
*Significant at P ≤0.05 
 
It can be seen from the table above that the odds of defaulting from TB treatment is three 
times more likely in  males compared to females (OR=3.05, 95%CI=1.60-5.80) keeping other 
variables in the model constant. Being a civil servants/professional decreases the likelihood 
of defaulting compared to doing personal business (OR=0.24, 95%CI=0.08-0.70). The odds of 
defaulting is three times higher in patients who were married than patients who were singles 
(OR=3.06, 95%CI=1.34-6.99). Similarly, patients who travelled out of locality during treatment 
had higher chances of defaulting (OR=6.87, 95%CI=3.19-14.80) compared to those who did 
not travelled. The concomitant use of TB drugs with other drugs (OR=1.95, 95%CI=1.02-3.73) 
and been counseled occasionally in the clinic by health workers (OR=0.05, 95%CI=0.99-3.71) 
were significantly associated with defaulting. The more concomitant medications a patient 
use with TB drugs, the more likely the patient will default in treatment.  
 
3.6.2 Evaluation of multivariate logistic regression model 
In this study, we did assess how well the multivariate logistic regression model fit the data in 
determining the factors that are strongly associated with defaulting. This was done using 
summary measure of ‘goodness of fit’ test. 
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The summary measure of goodness of fit test gives us an overall indication of how well the 
variables in the model fit the observed data in predicting the determinant factors of 
defaulting among TB patients placed on DOTS.  From our analysis, the full model containing 
all variables was statistically significant, (X
2
 =82.10, df=12 and P=0.000) indicating that the 
variables as a group were important in explaining the determinant factors of defaulting from 
DOTS among TB patients.  Similarly, Hosmer-Lemeshow test (X
2
=7.94, df=8 and P=0.439) 
indicated that the model adequately fit the data. The insignificant value of P=0.439 shows 
that the model performs well in explaining the determinant factors of defaulting and also 
indicated no significant difference in observed and  predicted TB treatment group. The model 
as a whole explained between 27.3% (Cox and Snell R square) and 37.1% (Nagelkerke R 
square) of the variations in the treatment group. The percentage accuracy in classification 
(PAC) of the model is 72.9% i.e. the model was able to classify correctly 72.9% of all cases. 
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4   CHAPTER IV:   DISCUSSION 
 
Tuberculosis (TB) is one of the most important infectious diseases globally. Case detection 
and treatment is the main method of prevention and control of TB. Directly Observed 
Treatment Short Course (DOTS) was developed to improve TB treatment globally. It has 
shown to be highly effective and affordable strategy for controlling TB and prevention of 
emergence and spread of resistant TB, It has also shown to be valuable in resource-poor 
communities (66,67). Defaulting from DOTS is a major impediment to effective TB 
chemotherapy globally and is one of the major causes of increased infectivity, poor 
treatment outcomes like treatment failure and drug resistance (68).  
 
The TB burden in Nigeria over the years has increased tremendously because of the HIV 
epidemics which has constituted a major problem in the treatment of TB (69). 
The current study was conducted to determine the extent of defaulting from DOTS and 
factors influencing defaulting in Benin City.  
 
The results show that the defaulting rate in this study was 23.8%, which is lower than reports 
from other studies in Nigeria, 44.2% in Ilorin (60), 27% in Ife (70) and 24% in central part of 
Edo State (71). The reason for the lower default rate might be due to differences in DOTS 
programme implementation, we observed during data collection that patients were 
reminded on phone prior to commencement of continuation phase to collect their drugs and 
also contacted on phone if they miss any appointment. 
 
4.1 Determinant factors of TB treatment defaulting 
4.1.1 Socio-demographic factors 
The association between the socio-demographic factors and defaulting produced some 
interesting findings. It was observed that those who were married had a higher risk of 
defaulting (table 21), also there was a significant association between defaulting and being 
married. This is contrary to our expectation that having a partner will most likely reduce the 
odds of defaulting. A possible explanation for this could be the influence of sociocultural 
impact of stigma, isolation or loss of economic power associated with TB which could 
influence separation or even divorce thus impacting negatively on treatment adherence. Our 
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finding is contrary to studies in Kenya and China where patients who were singles had higher 
risk of defaulting compared to patients who were married (72,73). However, this finding is 
similar to a study in India (74) which indicated a statistically significant association between 
patients who were married and defaulting, the odds of defaulting was higher in patients who 
were married. Likewise, studies in Nepal (75) and Ghana (76) showed a larger number of 
patients who were married defaulted compared to those unmarried but there was no 
significant association with defaulting. They attributed the insignificant association between 
defaulting and being married to the influence of the small sample size in reducing the 
number of variables that were adjusted for in the multivariate analysis. 
 
From the multivariate analysis (table 21), being a male is a significant predictor of defaulting 
in this study. There was a significant association between male sex and defaulting. Male 
patients had three times the risk of defaulting from TB treatment compared to their female 
counterparts. This is consistent with reports from studies in Nigeria (57,77), Kenya (72), 
Ghana (78), India (79,80), South Africa (81), Malaysia (82) and Madagascar (83). The Nigerian 
study (77) reported that male sex was a good predictor of poor treatment outcome. The 
reason for these could be attributed to the fact that in most societies, men are the bread 
winners in the family, they tend to leave home early for work in order to provide for their 
families and thus find it difficult to comply with daily clinic attendance (57). 
 
Another important finding in this study was the significant association of defaulting with high 
status occupation (civil servants/professional). Taking business as the reference occupation, 
the odds of defaulting reduces with a high status occupation (table 21) with the exemption of 
patients who were students or unemployed. This finding is more or less similar to studies in 
Nepal (75) and Ethiopia (84) which showed that patients who were unemployed and had low 
status occupation had higher risk of defaulting compared to those who were in high status 
occupation. However, a Nigerian study (85) found that type of occupation had no effect on 
defaulting. It is expected a high status occupation brings a high income which most likely 
promotes adherence to treatment. The significant association with defaulting in our study is 
similar to a study in India (86) which discovered that patients with high status occupation 
defaulted more compared to patients in low and middle status occupations, they attributed 
this to the fact that 40% of these patients left the hospital after retirement from public 
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service. It is possible that the significant association of high status occupation with defaulting 
in our study might be due to confounding effect of other variables in the analysis. However, 
studies in South Africa (87) and Vietnam (88) indicated that staff and patients of chest clinics 
believed that TB was a stigma and ‘dirty’ disease thus, some of them avoided seeking help 
from chest clinics.  
 
The current study did not show any significant association of monthly income with defaulting, 
this is similar to some earlier studies (84,89). However, some studies have shown that this 
factor greatly influences defaulting from TB treatment (72,75,76,86,90). The lack of influence 
of monthly income on defaulting in this study might be due to 142 (54.2%) cases of 
respondents whom monthly income was not applicable to and also decline from some 
patients in giving this information, thus reducing the sample size needed for comparison.   
 
4.1.2   Patient related factors  
This study has shown that patients who used other medications with TB drugs had a higher 
risk of defaulting compared to those who did not, also there was a significant association 
with defaulting. Studies carried out in Kenya (72), Hong Kong (91) and USA (92) indicated a 
significant association between defaulting and concomitant drug use with TB drugs.  
Similarly, it was also documented in Thailand (93) that the use of anti-retroviral drugs with TB 
drugs was strongly associated with defaulting. Studies in Russia (94) and Peru (95) found that 
the use of recreational and illicit drugs with TB drugs greatly influence defaulting from DOTS. 
The concomitant use of TB drugs with other drugs could lead to unwanted side effects which 
can significantly influence defaulting. A study has shown that the concurrent use of HIV 
medications with TB drugs increases the side effects associated with TB chemotherapy (96). 
Combining antiretroviral and TB drugs means taking many tablets daily, this can be difficult 
and challenging to most patients.  
 
Another important finding in this study is the significant association (P <0.001) of travelling 
outside locality during treatment with defaulting (table 21). We found that the risk of 
defaulting was much higher in patients who travelled outside treatment locality compared to 
those who did not (table 21). It was noted that most patients that travelled during the course 
of treatment did so for economic reasons like search for good jobs and business trips. TB has 
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been shown to be closely associated with low socioeconomic status (16, 70), most TB 
patients are from the lower class of the society and as such contend with both economic and 
health issues which is a big challenge. A similar finding was observed in one study (97) on the 
predictors of defaulting, it was shown that there was a significant association between 
traveling out during treatment and defaulting.  A study in Kenya (72)   indicated that from the 
150 patients who did not complete treatment, 15(12.5%) attributed their default to travelling 
away from treatment locality thus missing scheduled appointment. Similarly, a Nigerian study 
(98) showed that among the reasons given for defaulting was travelling away from treatment 
centre, though no association was shown with defaulting. Similarly, an Indian study (79) 
documented that a higher rate of migration from treatment centre was observed among 
patients who defaulted. They discovered that the migration was based mainly on 
occupational grounds. 
 
Our study also found that the main reason for defaulting was a feeling of improvement (table 
9). This is in line with studies from Ethiopia (45), Kenya (99) and India (100). Patients usually 
feel better shortly after initiation of treatment in the intensive phase because drugs used 
during this phase rapidly reduce the number of tubercle bacilli load. Thus, inadequately 
counseled patients may mistake the feeling of improvement as cure. Our study also found 
that majority of the defaulters (59.6%) stopped treatment in the continuation phase. This 
corroborates other studies in Nigeria (57), Ethiopia (45,89) and Singapore (101). However, 
some studies in Kenya (72), Hong Kong (91) and Brazil (102) have documented higher 
defaulter rate in the intensive phase of treatment.  
 
With regards to type of family support given to patients during treatment, we found in this 
study based on Chi square test that a reminder to take medications showed a significant 
association (P =0.02) with defaulting. It is expected that receiving family support will reduce 
the likelihood of defaulting all other factors remaining constant. However, in our study most 
of the defaulters admitted receiving family support in form of financial assistance, reminder 
to take medications, helping in household chores and prayers. It is possible that other factors 
may have influenced defaulting irrespective of the support received. Studies have shown the 
positive effect of family support in enhancing compliance (78,89,103,104,105,106). It was 
noted in these studies that family support in form of financial assistance, collection of 
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medications and emotional support have strong influence on patients’ adherence to TB 
treatment. 
 
4.1.3  Service provider factors 
We did find that occasional counseling about TB from service providers to patients had a 
significant association (P <0.001) with defaulting (table 21). Interestingly, we expected that 
the more the frequency of counseling the less the likelihood of defaulting. However, from our 
results we found that patients who admitted being given occasional counseling about TB 
treatment from service providers defaulted less compared to those who received counseling 
on each visit. Similarly, a study (97) reported a significant association between frequency of 
counseling and defaulting. Our finding is in contradiction with studies from Nigeria (50) and 
Senegal (53) which documented that inadequate counseling and provision of information by 
health care workers were the cause of TB defaulting. The finding in this study that fewer 
numbers of patients defaulted after receiving occasional counseling compared to patients 
who received counseling on each visit to the clinic might be due to differences in 
understanding and comprehending the information being given by health care workers.  
 
The provision of privacy to patients in the clinic has been shown to have an influence on TB 
compliance. A study in India (51) showed that lack of privacy was associated with defaulting. 
In our study however, the multivariate analysis did not show any significant association with 
defaulting, the univariate analysis did show a significant association. Providing privacy to 
patients in the clinic gives room for a good interaction between service providers and 
patients, in such conditions patients can freely express their fears, difficulties and other 
challenges they are experiencing. This can enhance treatment compliance in patients. A study 
in Ghana (76) found that 44% of patients who completed treatment admitted good patients’ 
provider interaction as the main motivating factor for completion of treatment. Similarly, a 
study in the Philippines (107) found that a cordial relationship between patients and health 
staff enhances an effective treatment in TB patients. However, some studies 
(89,100,108,109,84) have shown that a poor patient provider interaction influences 
defaulting. In Nigeria, the case load of TB over the years has increased this has led to an 
increased work load on the part of health workers who are overburdened caring for TB 
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patients and other patients thus giving patients adequate time and privacy in the clinic 
becomes a challenging task.    
 
4.2   Tuberculosis treatment factors 
A very interesting finding in our study is the significant association between the year of TB 
diagnosis with defaulting in the Chi square analysis (table 15). There was an increase in 
defaulting over the years from 2006 to 2009 with a decline in 2010 keeping in mind the 
exclusion of some patients who did not meet the inclusion criteria and those who could not 
remember the year of diagnosis (figure 12). The reason for this could be linked to the type of 
implementation put in place at the initial stage of DOTS programme which started in 2006 in 
one of the study centres (UBTH).It was noted that care providers in the clinic were rotated 
between the DOTS clinic and other wards in the hospital this could have a negative effect on 
patients’ follow up. It is also possible that patients were not appropriately referred to centres 
closer to their place of residence. With the improvement in patient selection and deployment 
of permanent staff to the DOTS clinic there was a reduction in default rate in 2010. However 
in contrast to our study, a Nigerian study (57) found that there was a decline over the years 
from 1997 to 2001 in defaulting rate. They ascribed this to the better programme 
management in selecting patients, eligibility of patients for treatment was based on 
proximity to the TB centre. Referrals were made to other centres for patients who live 
outside the locality. 
 
In this study, we did not find a significant association between time gap of emergence of 
symptoms and reporting to the clinic. We observed that most of the patients delayed 
between 1-2 months before seeking health care in the hospital (table 14). Contrary to our 
findings, a study (97) did find a significant association between duration of symptoms before 
seeing a doctor and defaulting. It was noted that the odds of defaulting was higher in 
patients who delayed more than 2 months before seeing a doctor than those who delayed 
between 1-2 months. 
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4.3  Perceptions, beliefs and attitudes of TB among treatment group 
Interestingly in this study, it was observed that some patients had the belief that TB can be 
hereditary. With the Chi square analysis, we did find a significant association with defaulting 
(P<0.001). A study in rural Vietnam (110) on the attitude to compliance of TB treatment did 
find that patients had the belief that TB is hereditary, it can be transmitted through the blood 
from generation to generation, although they did not indicate any association with non-
compliance. Another study in Timor Leste (111) discovered that TB is stigmatized because it is 
a hereditary disease. A Kenyan study (112), reported that patients attributed TB to causes 
such as hereditary predisposition, consumption of alcohol, smoking or witchcraft which often 
resulted in delayed health seeking in the clinic. From our findings regarding the cause of 
patents’ TB, it was noted that there was a significant difference (P <0.001) between 
defaulters and non-defaulters regarding spiritual attack as the cause of their TB. This belief 
could be attributed to the general religious belief regarding certain diseases in Nigeria. A 
study in Nigeria (113) documented that TB patients hold superstitious beliefs for the cause of 
TB, they attributed TB to spiritual attack from enemies, ancestral curse and the violation of 
cultural norms, although no association was shown with defaulting. We also found in our 
study that the use of herbal medication (bitter kola) had a significant association (P <0.001) 
with defaulting in Chi square analysis (table 12). The general belief that bitter kola has 
medicinal properties and also effective in treatment of cough from any source is very 
common in Nigeria.  A similar study (72) has likewise documented the influence of herbal 
medication use on defaulting. It was noted in the multivariate analysis that patients who used 
herbal medications had a higher risk of defaulting compared to those who did not. These 
findings have shown that in the African setting, the influence of socio-cultural and religious 
factors on defaulting from tuberculosis treatment cannot be underestimated.   
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5   CHAPTER V:  CONCLUSION AND RECOMMENDATION 
 
5.1   Conclusion 
This research work has provided us information regarding the magnitude of defaulting from 
DOTS in Benin City. We documented a defaulter rate of 23.8% from TB treatment which is 
relatively low compared to other areas in Nigeria. However, we cannot overrule the 
possibility of the effect of the exclusion criteria used in selecting the treatment group in 
reducing the defaulting rate.   
 
We also accessed the determinant factors associated with defaulting. Our results showed 
that male patients defaulted more compared to their female counterparts. Being a male is a 
significant contributor to defaulting. Similarly, being married had a strong association with 
defaulting. The likelihood of defaulting in patients who were married was three times higher 
compared to those who were singles. In this study, we found that high status occupation was 
a protective factor against defaulting compared to those who do personal business. A 
possible explanation for this could be that a high status employment yields good income 
which can enhance compliance to treatment all other factors being equal. Patients who 
travelled outside locality during treatment had a significant risk of defaulting compared to 
those who did not. The concomitant drug use of anti-tuberculosis drugs with other 
medications increases the risk of defaulting. It is possible that concomitant drug 
administration of other drugs with TB drugs means there are other comorbid conditions with 
tuberculosis, this can increase the likelihood of defaulting. We discovered that the odds of 
defaulting reduced when counseling to patients was done occasionally. This is interesting, 
because we did expect that the more patients are counseled on each visit to the clinic, the 
less likely they will default.    
 
Among patients that defaulted, the feeling of getting better, long distance to health facility 
and lack of money were the main reasons for stopping treatment. This finding underscores 
the need to adequately inform patients on the need to complete treatment and also consider 
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measures that will reduce the financial burden of associated TB cost.  
 
From the Chi square analysis, the year of TB diagnosis, the consumption of Bitter kola, family 
support in form of reminder to take medications, the belief that TB is hereditary and can also 
be caused by spiritual attack showed a significant association with defaulting, these give us 
an insight into the pattern of defaulting, the role of family support, perception, attitudes and 
religious beliefs among the treatment group. However, we do not know to what extent these 
factors influence defaulting as further research is needed in these areas. 
 
5.2   Strength and limitations of the study 
5.2.1    Strength  
• We collected data of TB patients way back to the inception of DOTS programme in the two 
study centres, thus a relatively large sample size was used in this study.  
• We used a better sampling technique and procedure in screening the study participants. 
• This study provided us important information on defaulting previously unavailable in Benin 
City. Thus, it can serve as a baseline for planning TB control strategies and also a platform on 
which other studies can build on. 
• We used recommended data management and analysis method. 
• We were able to give an insight into patients’ perception, religious beliefs and attitude 
towards TB and its influence on defaulting thus paving way for further qualitative research in 
this area.  
• We collected data both from interview sessions and hospital records. 
 
5.2.2   Limitations 
• Since this is a retrospective case control study, recall bias on the part of patient cannot be 
completely ruled out. 
• Selection bias In the sampling technique used, a sizeable number of patients were excluded 
from the study this could have some effect on the final results. 
• Due to limited information from the patients’ hospital records, we could not analyze hospital 
records in order to ascertain the management practice of TB by care providers. 
• It is possible that patients were misclassified from the hospital records as defaulters and non-
defaulters. 
64 
 
• We used only two DOTS centres in Benin City, thus our result cannot be generalized to the all 
of Benin City. 
• It is possible that the determinant factors of defaulting may have been over or under 
reported, thus over or under estimation of odds ratios, confidence interval and P values 
cannot be ruled out.  
 
5.3   RECOMMENDATIONS 
Based on our findings, we recommend the following: 
• Male patients should be encouraged, reassured and counseled continually on the need to 
complete treatment. The use of home visitor, DOT supporter or volunteers to supervise the 
administration of TB drugs should be instituted.   
• Family support, interest and participation should be encouraged through appropriate 
channels. 
• Adequate training for health service providers on the management of patients on 
concomitant drug administration with TB drugs. Provide in-service training to health care 
workers to enhance their competencies in regards to health education and communication 
skills.   
• Provisions should be made to patients travelling away from treatment centres during the 
course of treatment. Options like the provision of additional drugs or reporting to the nearest 
DOTS centre in the event of running at of drugs is desirable.     
• Provide an enabling environment that is conducive for good patient providers’ interaction. 
Patients should be accorded the room to express their feelings. This can serve as a basis for 
cordial relationship with care providers. 
• Measures should be taken to reduce the burden of associated TB cost incurred by patients in 
the form of provision of stipend for transportation or food rations. These will serve as a 
motivating factor for completion of treatment.  
 
5.4   Further research implication 
• Conducting a qualitative research on patients’ perception, attitudes and religious beliefs 
towards TB and its influence on defaulting will give an in-depth knowledge about these 
factors and also provide the opportunity to address their influence on defaulting. 
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7  Appendices 
                7.1  Appendix 1  
Participants information sheet 
Assessment of defaulting from DOTS and its determinants in Benin City, Nigeria 
Tuberculosis is a major public health problem in Nigeria and has been compounded by the HIV 
epidemic in recent times. Nigeria ranks 4th in the world in terms of incidence of TB. Current 
control and prevention of TB is by diagnosis and case detection through Directly Observed 
Treatment Short Course (DOTS) programme. Defaulting from treatment constitutes an 
infectious pool that sustains the continuous transmission of TB within the community, it is 
one of the problems facing TB control programmes. For effective control of TB to be achieved, 
the problem of defaulting must be addressed.  No study has been done on DOTS in Benin City 
determining the extent of defaulting, factors associated with defaulting and the management 
practice of DOTS. Thus, we are embarking on this study to assess the extent of defaulting from 
DOTS and find out factors associated with defaulting in Benin City. The result is expected to 
have a significant contribution for effective TB control and prevention in Benin City. 
 
What does the study bear? 
If you agree to participate, you will be asked questions about your TB treatment. Answering 
these question has no risk, whatsoever.  
 
What happens to the information about you? 
The information recorded about you will only be used for the purpose we have described 
above. All data will be processed using inclusion number, instead of using your name or other 
recognizable information. The private investigator will use private laptop for recording and 
storage of information. Only authorized personnel involved in the project will have access to 
your information. The information will be deleted once the project is completed, no later than 
2015. It will not be possible to identify you with the results of the study when it is published. 
 
 
 
 
77 
 
Voluntary Participation 
It is voluntary to participate in this study. You can withdraw your consent to participate in this 
study at any time without giving any reason. This will not affect your future treatment. If you 
would like to participate, you will give your consent using your signature on the last page.  
Further information about the Biobank, privacy and insurance are found below. 
 
Criteria for participation 
Participants of this study are TB Patients who completed treatment and discontinued 
treatment between August 2006 and December 2010.  
 
Duration of study 
The study will take place from August to December 2011. 
 
Duration of interview  
The interview may take up to 30 minutes of your time. 
 
Possible benefits 
Participants may not get direct benefits from the study 
 
Participants responsibility 
 The participant does not have any responsibility except providing information required for the 
study. They will be informed as soon as possible if new information becomes available that 
may affect participants` willingness to participate in the study. The project will not cover any 
expenses for the participants because they participate in the study.  
 
Privacy 
The information recorded about you is only stated in the questionnaire that you have seen 
today. There will not be a link with other registers. Only the investigators of the study have 
access to personally identifiable information, and all such information is kept confidential. 
 
Biobank 
We do not need biobank as we are not going to collect blood samples.  
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Right of access and deletion of information about you 
If you agree to participate in the study, you are entitled to have access to what information is 
collected about you. You are also entitled to correct any inaccuracies in the information we 
have on you. If you withdraw from the study, you can request to have the collected 
information about you deleted, unless the data is already entered in the analysis or used in 
scientific publications. 
 
Economy 
The study is funded by the University of Oslo 
 
Information on the outcome of the study 
Anyone participating in the study will be informed of the results. 
 
      7.2  Appendix 2 
         Declaration of consent  
I have read and understood the information given above; I also understood the purpose and 
benefits of the research work. I am aware that participation in the study is absolutely 
voluntary and also I can withdraw at any time during the course of the study without any 
consequences on me having access to health care services now or in the future. I am also 
aware that the information I give will be used strictly for research purpose and also will be 
kept confidential. Finally, I declare that I have agreed to participate in the study in the 
presence of the witness. 
  
Name of participant………………………………                Name of witness…………………………… 
Signature………………….                                              Signature………………….                                                                                                                
Date………………….                                                                 Date………………   
Name of investigator…………………………… 
Signature………………… 
Date………………… 
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Note: Since English is the official language in the study area, there is no translation in another 
language. A copy of the research protocol and a letter from my institute has already been sent 
to the study area for approval. 
 
7.3    Appendix 3          QUESTIONNAIRE 
This questionnaire will be used as a tool for my research work titled defaulting from DOTS  and 
its determinants in Benin City. The study is a partial fulfillment of the Master of philosophy in 
international community health at the University of Oslo, Norway. Please your participation 
will be highly appreciated and your response to these questions will go a long way in 
improving TB control in Benin City and in Nigeria in general. 
Serial Number…………. 
 
SECTION A:  BIODATA AND  DEMOGRAPHIC INFORMATION 
1. Age (years):       1 =0-15;       2 =16-31;       3 =32-47;       4 =48-63;       5 =>64 
2. Sex    Male =1     Female =2                                                   
3. Education:    No formal education = 1; Primary =2; Secondary =3; Tertiary =4; Others =5 
4. Marital status:  Married =1; Single =2; Divorced =3; Widow/Widower =4; Separated =5    
5. Occupation:   Student =1; Business =2; Civil servant =3; Professional =4; Farmer =5;    
     Unemployed =6; Others =7 
6. Religion:   Christian =1; Muslim =2; Traditionalist = 3; Others  =4  
7. Ethnicity:   Bini =1; Ishan =2;  Etsako =3;  Owan =4;  Ibo =5;  Yoruba =6;  Hausa =7;   
     Others =8. 
8. What is your family size?  1 =1-4;   2 = 5-8;   3  = >8 
9. What is your estimated income per month? N________________________ 
 
    SECTION B:  TB TREATMENT DETAILS 
1.  When did you first experience the symptoms before reporting to the hospital? 
      1= <1month;     2 = 1-2months;      3 = 2-3 months;   4 = >3 months; 
2.   Date of diagnosis……………….   
3.   Type of diagnosis    X-ray =1; Sputum smear =2; Culture =3; Mantoux =4;  
       5 =Clinical observation; 6 =X-ray and Sputum smear 
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4. Date treatment started: ……………… 
5. Type of drug:  Isoniazid =1; Rifampicin =2; Ethambutol =3;  Pyrazinamide =4;   
     Streptomycin =5     
6. What did you do when you first experienced the symptoms?  
 
 
 
 
 
 
 
 
 
 
 
 
 
SECTION C:  PATIENT RELATED FACTORS 
        1. How did you get to the clinic?    1=Walked    2 = Took a vehicle   3= Took a bike   3=Others 
2. Do you own a car or bike? 1 =Yes; 2 = No 
3. How much did you spend on transportation to the clinic and back home per visit?   
N………………………. 
4.Who paid the bills?  1= Self; 2 =Family members; 3 =Husband; 4 =Wife; 5 = Others 
5. When you started the hospital treatment, did you travel outside your locality?  1 =Yes  
     2 =No 
    If yes why did you travel? ..…………………………………………………………………………………… 
6. Did your drugs get finished before you returned? 1 =Yes    2 =No 
7.  What did you do when your drugs got finished? 1 = Contacted the nearest hospital; 2 =   
      Waited till return; 3 =Did not return for further drugs; 4 =Returned immediately for  
       treatment 
8. Did you use other drugs alongside the TB drugs?  Yes =1; No =2 
     If yes, which one?  1= Pain reliever;   2 = Multivitamins;   3 = Antihypertensive drugs;  
      4 = Ant-diabetic drugs;   5 =Antiretroviral drugs; 6 =Others     
9. Did you ever stop taking the TB drugs?   1 =Yes   2 =No 
10. What was your reason for stopping the treatment? (Tick the appropriate ones) 
 Multiple response TICK 
6A Self-medication     
6B Use the service of traditional 
healer   
 
6C Patronized patent  chemist store  
6D Went to the pharmacy     
6E Went to the hospital  
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11. What phase of treatment did you stop taking the TB drugs? 
1 =Intensive phase (1st 2 months of treatment); 2 =Continuation phase (6 months of            
treatment) 
12.  Were you informed by health workers that you must complete your treatment 1 =Yes 
        2 =Yes 
      13.  Do you know the consequences of not completing treatment?  1 =Yes 2 =No 
       If yes, what are the consequences? 1 =Organisms build resistance; 2 =Infect those  
       around; 3 =Death 
    14.  Which of the following do you use?  
 
 
 
 
 
 
 
 
 
             Reason Yes (1)   No (2) 
10A Was feeling better     
10B Long distance to health facility   
10C Condition worsened/did not improve   
10D Thought hospital treatment will not cure the 
disease  
  
10E Medication side effects   
10F Dissatisfied by the services  provided   
10G Lack of money     
10H Delivery/Maternal leave   
10I Others (specify)   
14A Tobacco  
14B Alcohol  
14C Bitter kola  
14D Honey  
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15       What support did your family render regarding your treatment? 
 
 
 
 
 
 
 
 
 
SECTION D: Patient’s perceptions, attitude and beliefs of TB 
1. Did your family and friends knew that you were suffering from TB?    1 =Yes  2 = No 
   2.  If No, why?  (You can tick more than one) 
 
  
 
 
 
 
 
3. What is the cultural and religious beliefs of TB in your locality? 
 
 
 
 
 
 
 
 
 
 
 
 You can tick more than one Tick 
15A Reminded me to take my drugs  
15B Supported financially  
15C Helping in household chores  
15D Helping in prayers  
15E Others (specify)  
15F No support  
  TICK 
2A Fear of  isolation  
2B Fear of eviction  
2C Fear of divorce  
2D         Fear of losing your job  
 You can tick more than one Tick  
3A Caused by witchcraft/spiritual means    
3B Punishment for dishonest/bad deeds      
3C Hereditary    
3D Can be cured by prayers only      
3E Don’t know  
3F Others (specify)  
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4.     What is the attitude of your community members towards TB?           
 
 
 
 
 
 
 
 
 
 
5.         What do you think was the cause of your TB?  (You can tick more than one) 
 
 
 
 
 
 
 
 
 
 
 
SECTION E: SERVICE PROVIDER RELATED FACTORS 
1. How often were you counseled about TB by health care providers? 
     1= On the first visit;   2 = On each visit;   3 = Once a while 
2.  Did the health worker provided privacy while attending to you at the hospital? 
      1 =Yes 2 =No 
3.  How were you served with your drugs on each visit to the clinic? 
   1 =Daily dose;    2 =Weekly dose;    3 = Once in 2 weeks; 4 =Monthly   5=Others 
4.   Did the health care providers educate you on the disease condition?  1 =Yes 2 =No  
5.   Did the health care providers give card indicating your review date?   1 =Yes 2 =No 
 You can tick more than one Tick  
4A TB is associated with poverty  
4B TB is a deadly disease thus should be feared  
4C TB is associated  with stigma     
4D Can be cured only by traditional means  
4E Can be treated with orthodox medicines  
4G Others (specify)  
  Tick  
5A Malnutrition     
5B Poor hygiene    
5C Overcrowding  
5D Alcohol intake  
5E Tobacco intake  
5F Stress  
5G Spiritual attack  
5H Others(Specify)  
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6.  How long did you have to wait at the clinic on each visit before you were served with 
      your drugs? 
     1 = <30 minutes    2 =1-2hrs   3 =3-4hrs   4 = > 4hrs  
 
 
                                                       THANK YOU 
 
 
 
